date,username,to,replies,retweets,favorites,text,geo,mentions,hashtags,id,permalink
2020-03-13 15:00:26,NeurologyToday,,0,2,0,"For patients with #narcolepsy, solriamfetol may provide short-term improvement in work productivity, health-related quality of life, and functional status via @ElsevierConnect https://bit.ly/2TKLoYu",,@ElsevierConnect,#narcolepsy,1238480042042306561,https://twitter.com/NeurologyToday/status/1238480042042306561
2020-03-10 18:11:44,genphys,,0,0,0,"Solriamfetol Improves Several Quality of Life Markers in People With Narcolepsy - Neurology Advisor - +GENERAL PHYSICS LABORATORY (GPL) Solriamfetol Improves Several Quality of Life Markers in People With Narcolepsy Neurology Advisor https://www.genphys.com/science-news/solriamfetol-improves-several-quality-of-life-markers-in-people-with-narcolepsy-neurology-advisor",,,,1237441021815865344,https://twitter.com/genphys/status/1237441021815865344
2020-03-10 15:37:54,BrainSightsApp,,0,0,0,"Solriamfetol Improves Several Quality of Life Markers in People With Narcolepsy - Neurology Advisor via BrainSights for iOS ",,,,1237402308406845442,https://twitter.com/BrainSightsApp/status/1237402308406845442
2020-03-07 14:02:45,BSeay05,,0,0,0,"Two studies on the use of Solriamfetol in Narcolepsy and OSA patients Narcolepsy - https://www.ncbi.nlm.nih.gov/pubmed/30694576 OSA - https://www.atsjournals.org/doi/full/10.1164/rccm.201806-1100OC #SleepMed #GASP20",,,#SleepMed #GASP20,1236291199511801856,https://twitter.com/BSeay05/status/1236291199511801856
2020-03-07 13:48:18,BSeay05,,0,0,0,"The newest treatment for Narcolepsy, Solriamfetol (Sunosi) #GASP20 #SleepMed",,,#GASP20 #SleepMed,1236287561095688193,https://twitter.com/BSeay05/status/1236287561095688193
2020-02-27 04:01:33,SuperBobSaget,,3,0,0,"anyone tried #SUNOSI (solriamfetol)? how does it compare to Nuvigil / Provigil?",,,#SUNOSI,1232878411808485376,https://twitter.com/SuperBobSaget/status/1232878411808485376
2020-02-26 22:02:47,dtwResearchInc,,0,0,0,"Stay awake, amazing things happen during the day! #JazzPharmaceuticals #sunosi #solriamfetol #narcolepsy #excessivedaytimesleepiness #EDS #obstructivesleepapnea #OSA #sleepapnea #stayawake #sleepdisorder #centralnervoussystem #interestingmarketing #dtwmarketspotlight",,,#JazzPharmaceuticals #sunosi #solriamfetol #narcolepsy #excessivedaytimesleepiness #EDS #obstructivesleepapnea #OSA #sleepapnea #stayawake #sleepdisorder #centralnervoussystem #interestingmarketing #dtwmarketspotlight,1232788122905333767,https://twitter.com/dtwResearchInc/status/1232788122905333767
2020-02-13 02:23:25,Nat_Sleep,,0,0,2,"Solriamfetol (sunosi) has received marketing approval in Europe. ",,,,1227780283400781824,https://twitter.com/Nat_Sleep/status/1227780283400781824
2020-02-12 13:40:22,SleepResearch_,,0,0,0,"A Phase I, Randomized, Crossover, Open-label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food. https://ift.tt/2SjpESQ",,,,1227588254716825608,https://twitter.com/SleepResearch_/status/1227588254716825608
2020-02-09 23:00:33,wileyneurology,,0,0,4,"Enjoy this Top Accessed article in Annals of Neurology - A randomized study of solriamfetol for excessive sleepiness in narcolepsy #BestofNeuro2019 #openaccess @TheNewANA1 http://ow.ly/8gVz30q9ay0",,@TheNewANA1,#BestofNeuro2019 #openaccess,1226642065850802176,https://twitter.com/wileyneurology/status/1226642065850802176
2020-02-08 23:17:38,psychopharmacol,,1,0,1,"Pitolisant, an H3r antagonist, and solriamfetol, a DA and NE reuptake inhibitor, are the most recently approved treatments for excessive daytime sleepiness associated with narcolepsy, New agents are being tested:",,,,1226283979608854533,https://twitter.com/psychopharmacol/status/1226283979608854533
2020-01-28 13:01:10,MontefioreWake,,0,0,2,"Sunosi (solriamfetol) approved in Europe to treat excessive daytime sleepiness in patients with #Narcolepsy and #ObstructiveSleepApnea",,,#Narcolepsy #ObstructiveSleepApnea,1222142574598729729,https://twitter.com/MontefioreWake/status/1222142574598729729
2020-01-27 22:45:50,PharmaNews,,0,0,0,"MSL DAILY PHARMA NEWS - EMA APPROVAL JAZZ NARCOLEPSY DRUG “Jazz Pharmaceuticals announced that the European Commission approved Sunosi (solriamfetol) to improve wakefulness and reduce excessive daytime sleepiness… https://www.instagram.com/p/B71yEWcp4os/?igshid=189zdy520cwcc",,,,1221927320539320323,https://twitter.com/PharmaNews/status/1221927320539320323
2020-01-23 20:45:02,GMPnewsNet,,0,0,0,"EC Has Approved Solriamfetol - https://is.gd/bk5Pzv",,,,1220447371668135936,https://twitter.com/GMPnewsNet/status/1220447371668135936
2020-01-23 17:00:07,PharmaReview,,0,0,0,"EU marketing authorisation has been given to Sunosi (solriamfetol) for excessive daytime sleepiness in adults with #narcolepsy or obstructive #sleepapnea http://bit.ly/38A42XG",,,#narcolepsy #sleepapnea,1220390769204322305,https://twitter.com/PharmaReview/status/1220390769204322305
2020-01-23 13:22:51,ClientPharmaLtd,,0,0,0,"Jazz Pharmaceuticals has received a European Marketing Authorisation for Sunosi (solriamfetol) as a treatment for excessive daytime sleepiness in adults with narcolepsy and obstructive sleep apnoea. http://www.pharmatimes.com/news/sunosi_approved_in_europe_for_narcolepsy,_sleep_apnoea_1323129",,,,1220336092005748738,https://twitter.com/ClientPharmaLtd/status/1220336092005748738
2020-01-22 12:38:21,ScottMcKenzieCo,,0,0,0,"Jazz Pharmaceuticals has received a European Marketing Authorisation for Sunosi (solriamfetol) in #narcolepsy and #obstructivesleepapnoea. #sleep",,,#narcolepsy #obstructivesleepapnoea #sleep,1219962506413772800,https://twitter.com/ScottMcKenzieCo/status/1219962506413772800
2020-01-21 16:07:29,HypersomniaNews,,0,0,7,"The European Commission approved Jazz Pharmaceuticals’ Sunosi (solriamfetol) to improve wakefulness and reduce excessive daytime sleepiness in adults with #narcolepsy (with or without cataplexy) or obstructive sleep apnea. #BeyondSleepy #IH #KLS #OSA https://tinyurl.com/JazzEU",,,#narcolepsy #BeyondSleepy #IH #KLS #OSA,1219652745013030912,https://twitter.com/HypersomniaNews/status/1219652745013030912
2020-01-21 13:56:12,kells_jensen,,1,0,2,"Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea | Jazz Pharmaceuticals plc ",,,,1219619708699389952,https://twitter.com/kells_jensen/status/1219619708699389952
2020-01-20 17:17:41,pharma_jonpi,,0,0,2,"Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea .@JazzPharma https://www.prnewswire.com/news-releases/jazz-pharmaceuticals-receives-eu-marketing-authorisation-for-sunosi-solriamfetol-for-excessive-daytime-sleepiness-in-adults-with-narcolepsy-or-obstructive-sleep-apnea-300989638.html",,@JazzPharma,,1219308024323592192,https://twitter.com/pharma_jonpi/status/1219308024323592192
2020-01-20 16:24:52,NoahBlaineNews,,0,0,0,"Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea ",,,,1219294735308926976,https://twitter.com/NoahBlaineNews/status/1219294735308926976
2020-01-20 16:14:19,NoahBlaineNews,,0,0,0,"Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea https://noahsrss.wordpress.com/2020/01/20/jazz-pharmaceuticals-receives-eu-marketing-authorisation-for-sunosi-solriamfetol-for-excessive-daytime-sleepiness-in-adults-with-narcolepsy-or-obstructive-sleep-apnea/",,,,1219292078330601473,https://twitter.com/NoahBlaineNews/status/1219292078330601473
2020-01-20 16:02:04,CrweWorld,,0,0,0,"Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime Sleepines http://crweworld.com/article/news-provided-by-pr-newswire/1385051/jazz-pharmaceuticals-receives-eu-marketing-authorisation-for-sunosi-solriamfetol-for-excessive-daytime-sleepiness-in-adults-with-narcolepsy-or-obstructive-sleep-apnea",,,,1219288996439707648,https://twitter.com/CrweWorld/status/1219288996439707648
2020-01-20 15:40:28,otcdynamics,,0,0,0,"$JAZZ Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi® (solriamfetol) for Excessive Daytime https://www.otcdynamics.com/jazz-jazz-pharmaceuticals-receives-eu-marketing-authorisation-for-sunosi-solriamfetol-for-excessive-daytime-sleepiness-in-adults-with-narcolepsy-or-obstructive-sleep-apnea/?utm_campaign=twitter&amp;utm_medium=twitter&amp;utm_source=twitter",,,,1219283559044784135,https://twitter.com/otcdynamics/status/1219283559044784135
2020-01-12 21:36:03,Sleep_Bio,,0,1,0,"Measures of functional outcomes work productivity and quality of life from a randomized phase 3 study of solriamfetol in participants with narcolepsy. http://bioportfol.io/RMw165 #sleep",,,#sleep,1216473940681379840,https://twitter.com/Sleep_Bio/status/1216473940681379840
2020-01-10 19:50:27,NDEWSNews,mevansbrown,0,0,0,"Solriamfetol (2-amino-3-phenylpropyl carbamate) - including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible - placed in Schedule IV (effective January 7, 2020). DEA received 1 response during comment period. ",,,,1215722591559782400,https://twitter.com/NDEWSNews/status/1215722591559782400
2020-01-10 16:08:56,mevansbrown,,0,3,4,"US DEA: Schedules of Controlled Substances: Placement of solriamfetol in Schedule IV (final rule) ",,,,1215666843932860418,https://twitter.com/mevansbrown/status/1215666843932860418
2019-12-25 08:30:58,chrisvcsefalvay,urbanx_f,0,0,4,"We also got a new Duchenne antisense drug, the first SINE drug for multiple myeloma, the first NDRI for narcolepsy (solriamfetol), the first transthyretin stabiliser (tafamidis), and the first NHE3 inhibitor (for IBS w/constipation). That's all just THIS year.",,,,1209753387887136768,https://twitter.com/chrisvcsefalvay/status/1209753387887136768
2019-11-25 20:00:22,MontefioreWake,,0,0,0,"If approved, Solriamfetol (Sunosi) will be the only licensed therapy in Europe for the treatment of excessive daytime sleepiness! ",,,,1199055247316000768,https://twitter.com/MontefioreWake/status/1199055247316000768
2019-11-25 18:46:14,CTIClinical,,0,0,1,"Congrats to our friends and partners at @JazzPharma on receiving support from a panel of the @EMA_News for Solriamfetol! This sleep disorder treatment is designed for those that suffer from both narcolepsy and obstructive sleep apnea. #EMA #SleepDisorders",,@JazzPharma @EMA_News,#EMA #SleepDisorders,1199036588996661254,https://twitter.com/CTIClinical/status/1199036588996661254
2019-11-22 12:33:13,pharmjournalist,,0,0,0,"Jazz Pharma’s Sleepiness Drug Solriamfetol Gets CHMP Recommendation http://bit.ly/37q3VhH #DRUGS #pharmacy #pharmaceutical",,,#DRUGS #pharmacy #pharmaceutical,1197855551507447808,https://twitter.com/pharmjournalist/status/1197855551507447808
2019-11-20 14:27:04,Pharmamarketeer,,0,0,0,"EMA committee recommends approval for Jazz Pharma’s solriamfetol to improve wakefulness &amp; reduce EDS in adults with narcolepsy/obstructive sleep apnea http://dlvr.it/RJhYNk",,,,1197159428216147973,https://twitter.com/Pharmamarketeer/status/1197159428216147973
2019-11-20 13:09:46,Pharmamarketeer,,0,0,0,"EMA committee recommends approval for Jazz Pharma's solriamfetol to improve wakefulness &amp; reduce EDS in adults with narcolepsy/obstructive sleep apnea - ",,,,1197139976242237440,https://twitter.com/Pharmamarketeer/status/1197139976242237440
2019-11-19 19:09:00,Medscape,,0,2,8,"EMA panel recommends solriamfetol to improve wakefulness and reduce excessive daytime sleepiness in narcolepsy, OSA. ",,,,1196867990949703681,https://twitter.com/Medscape/status/1196867990949703681
2019-11-19 16:40:11,PlexusVentures,,0,0,0,"#JazzPharmaceuticals Receives Positive #CHMP Opinion for #Solriamfetol to Improve #Wakefulness and Reduce Excessive Daytime #Sleepiness in Adults with #Narcolepsy or Obstructive #SleepApnea https://www.pharmiweb.com/press-release/2019-11-18/jazz-pharmaceuticals-receives-positive-chmp-opinion-for-solriamfetol-to-improve-wakefulness-and-reduce-excessive-daytime-sleepiness-in-adults-with-nar#.XdLCx0MyJOU.twitter @pharmiweb_com @JazzPharma",,@pharmiweb_com @JazzPharma,#JazzPharmaceuticals #CHMP #Solriamfetol #Wakefulness #Sleepiness #Narcolepsy #SleepApnea,1196830538788683778,https://twitter.com/PlexusVentures/status/1196830538788683778
2019-11-18 21:09:00,MedscapePharm,,0,1,0,"EMA panel recommends #solriamfetol to improve wakefulness and reduce excessive daytime sleepiness in narcolepsy, OSA. http://ms.spr.ly/6018TTNjr",,,#solriamfetol,1196535801909317634,https://twitter.com/MedscapePharm/status/1196535801909317634
2019-11-18 16:55:00,MedscapeNeuro,,0,0,3,"EMA panel recommends solriamfetol to improve wakefulness and reduce excessive daytime sleepiness in narcolepsy OSA. http://ms.spr.ly/6011TT7NV",,,,1196471881089597440,https://twitter.com/MedscapeNeuro/status/1196471881089597440
2019-11-17 14:16:06,MyNeuroNewscom,,0,0,0,"(Corrigendum: A Randomized Study of Solriamfetol for Excessive Sleepiness in Narcolepsy) has been published on - https://myneuronews.com/uncategorized/corrigendum-a-randomized-study-of-solriamfetol-for-excessive-sleepiness-in-narcolepsy/",,,,1196069502921904128,https://twitter.com/MyNeuroNewscom/status/1196069502921904128
2019-11-16 18:09:00,MedscapeNeuro,,0,6,6,"EMA panel recommends solriamfetol to improve wakefulness and reduce excessive daytime sleepiness in narcolepsy OSA. http://ms.spr.ly/6015TTNjc",,,,1195765728470863874,https://twitter.com/MedscapeNeuro/status/1195765728470863874
2019-11-15 22:04:37,_timos_,,0,2,0,"European advisory group backs Jazz Pharma's solriamfetol - Seeking Alpha http://dlvr.it/RJN6HL &gt;&gt;&gt; http://lqventures.com #strategy #competitiveintelligence #marketing #healthcare #productmarketing #biotech #pharmaceutical #pharma",,,#strategy #competitiveintelligence #marketing #healthcare #productmarketing #biotech #pharmaceutical #pharma,1195462634218196992,https://twitter.com/_timos_/status/1195462634218196992
2019-11-15 16:18:07,BrainSightsApp,,0,0,0,"EMA Panel Backs Solriamfetol (Sunosi) for Narcolepsy, OSA - Medscape - Neurology via BrainSights for iOS ",,,,1195375435200290816,https://twitter.com/BrainSightsApp/status/1195375435200290816
2019-11-15 14:03:48,HSMN_com,,0,0,0,"HSMN: Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea https://shar.es/a3WfVg",,,,1195341632071229441,https://twitter.com/HSMN_com/status/1195341632071229441
2019-11-15 13:49:59,Briefingcom,,0,0,0,"$JAZZ: Jazz Pharma confirms positive CHMP Opinion for Solriamfetol http://bit.ly/2KoOXOW",,,,1195338156528111617,https://twitter.com/Briefingcom/status/1195338156528111617
2019-11-15 12:37:41,CrweWorld,,0,0,0,"Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Day ",,,,1195319960160980992,https://twitter.com/CrweWorld/status/1195319960160980992
2019-11-15 12:28:12,MasdelMedio,,0,0,0,"Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea",,,,1195317575070212098,https://twitter.com/MasdelMedio/status/1195317575070212098
2019-11-15 12:24:03,StckPro,,0,1,0,"$JAZZ NEW ARTICLE : European advisory group backs Jazz Pharma's solriamfetol https://dashboard.stck.pro/news.php?ticker=JAZZ&amp;rowid=1104790",,,,1195316528830468096,https://twitter.com/StckPro/status/1195316528830468096
2019-11-15 12:13:16,ProVesting,,0,0,0,"$JAZZ: European advisory group backs Jazz Pharma’s solriamfetol: https://www.StockNewsWires.com/jazz-european-advisory-group-backs-jazz-pharmas-solriamfetol/",,,,1195313818710224896,https://twitter.com/ProVesting/status/1195313818710224896
2019-11-15 12:11:37,newsfilterio,,0,1,0,"European advisory group backs Jazz Pharma's solriamfetol $JAZZ",,,,1195313401066483713,https://twitter.com/newsfilterio/status/1195313401066483713
2019-11-15 12:07:18,MarketCurrents,,0,1,1,"$JAZZ - European advisory group backs Jazz Pharma's solriamfetol https://seekingalpha.com/news/3519693-european-advisory-group-backs-jazz-pharmas-solriamfetol?source=feed_f&amp;utm_campaign=twitter_automated&amp;utm_content=news&amp;utm_medium=social&amp;utm_source=twitter",,,,1195312314938843137,https://twitter.com/MarketCurrents/status/1195312314938843137
2019-11-15 12:07:11,otcdynamics,,0,1,0,"$JAZZ Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce http://bit.ly/32NY5Dg",,,,1195312285172084736,https://twitter.com/otcdynamics/status/1195312285172084736
2019-11-15 12:04:55,NoahBlaineNews,,0,0,0,"Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea https://noahsrss.wordpress.com/2019/11/15/jazz-pharmaceuticals-receives-positive-chmp-opinion-for-solriamfetol-to-improve-wakefulness-and-reduce-excessive-daytime-sleepiness-in-adults-with-narcolepsy-or-obstructive-sleep-apnea/",,,,1195311717292675074,https://twitter.com/NoahBlaineNews/status/1195311717292675074
2019-11-15 12:00:31,marketcheetah,,0,0,0,"Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive ",,,,1195310607978942464,https://twitter.com/marketcheetah/status/1195310607978942464
2019-11-15 11:47:37,newsfilterio,,0,1,0,"Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in.. $JAZZ https://newsfilter.io/articles/jazz-pharmaceuticals-receives-positive-chmp-opinion-for-solriamfetol-to-improve-wakefulness-and-redu-f5078d9e8a5d85758dec61b2e24f468c",,,,1195307361218359297,https://twitter.com/newsfilterio/status/1195307361218359297
2019-11-15 11:45:43,ZoZoStockwatch,,0,1,1,"$JAZZ: Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea",,,,1195306883508256771,https://twitter.com/ZoZoStockwatch/status/1195306883508256771
2019-11-15 11:17:21,EURegulatory,,0,0,0,"Summary of opinion: Sunosi,solriamfetol, 14/11/2019, Positive: https://ift.tt/32P8Bdl #pharma #regulatory",,,#pharma #regulatory,1195299745209688064,https://twitter.com/EURegulatory/status/1195299745209688064
2019-11-14 16:37:22,SleepResearch_,,0,1,1,"Solriamfetol (Sunosi) for excessive daytime sleepiness. https://ift.tt/2ObQTLN",,,,1195017892481437698,https://twitter.com/SleepResearch_/status/1195017892481437698
2019-10-21 19:10:42,EmmGeezee,,0,0,1,"Learning about solriamfetol’s effect on sleep in the Treatment of Sleep Disorders in the 21st Century session! Positive effect on wakefulness, no shown negative effect on sleep in this study. #CHEST2019 #CHESTsleep #",,,#CHEST2019 #CHESTsleep,1186359171064762368,https://twitter.com/EmmGeezee/status/1186359171064762368
2019-10-11 10:05:05,BrainSightsApp,,0,0,0,"Common Treatment Emergent Adverse Effects of Solriamfetol in Patients With OSA and Narcolepsy - Neurology Advisor via BrainSights for iOS ",,,,1182597982010654720,https://twitter.com/BrainSightsApp/status/1182597982010654720
2019-09-30 08:02:17,whambamboogie,,1,0,1,"Hey all, I just learned that #Sunosi (Solriamfetol) has great effects on EDS! Has anyone any comments on this? It‘s been known under the trial name JZP-110 #narcolepsy #nchat",,,#Sunosi #narcolepsy #nchat,1178580812024954881,https://twitter.com/whambamboogie/status/1178580812024954881
2019-09-22 18:11:37,BrandonPetersMD,,0,0,0,"Sunosi represents a brand new stimulant medication available for the treatment of sleepiness in both narcolepsy and sleep apnea. https://www.verywellhealth.com/sunosi-4706541 #WorldNarcolepsyDay #sleep #sleepy #sunosi #solriamfetol #narcolepsy",,,#WorldNarcolepsyDay #sleep #sleepy #sunosi #solriamfetol #narcolepsy,1175835055526039553,https://twitter.com/BrandonPetersMD/status/1175835055526039553
2019-09-07 14:09:26,PeterTodd_,,0,0,0,"Interesting discussion by nurse Docherty of Solriamfetol for narcolepsy as an additional option https://en.m.wikipedia.org/wiki/Solriamfetol #NUK2019",,,#NUK2019,1170338288848252930,https://twitter.com/PeterTodd_/status/1170338288848252930
2019-09-06 11:24:09,rplenge,,1,5,18,"Catching up on genetic support for FDA approved therapies in 2019. Interesting connection between solriamfetol (approved for excessive sleepiness) and SLC6A3 (associated with sleep duration). https://www.targetvalidation.org/target/ENSG00000142319/associations?fcts=datatype:genetic_association",,,,1169934305847599104,https://twitter.com/rplenge/status/1169934305847599104
2019-08-29 19:10:20,BrandonPetersMD,,0,0,5,"Check out information on the new stimulant for excessive sleepiness due to narcolepsy and sleep apnea called Sunosi (solriamfetol) from @JazzPharma. https://www.verywellhealth.com/sunosi-4706541 #sleep #narcolepsy #sleepapnea #Sunosi #solriamfetol #sleepiness #stimulant",,@JazzPharma,#sleep #narcolepsy #sleepapnea #Sunosi #solriamfetol #sleepiness #stimulant,1167152520894042118,https://twitter.com/BrandonPetersMD/status/1167152520894042118
2019-08-28 13:43:16,HealioPulm,,0,0,0,"#Solriamfetol increased wakefulness and reduced sleepiness in #OSA, according to a study published in @ATSBlueEditor #sleepapnea @atscommunity https://www.healio.com/pulmonology/sleep-disorders/news/online/%7Bbef3dd9e-43ac-4076-9374-90599fa56ecf%7D/solriamfetol-improves-wakefulness-sleepiness-in-obstructive-sleep-apnea",,@ATSBlueEditor @atscommunity,#Solriamfetol #OSA #sleepapnea,1166707826925998080,https://twitter.com/HealioPulm/status/1166707826925998080
2019-08-28 10:00:39,Yousef_qurashi,,0,3,2,"USFDA have approved new treatment for narcolepsy: 1- Pitolisant: for narcolepsy type 2 (narcolepsy without cataplexy) 2- Solriamfetol: also for narcolepsy type 2 and sever sleepiness for patients with OSA.",,,,1166651803678760960,https://twitter.com/Yousef_qurashi/status/1166651803678760960
2019-08-23 13:00:10,MedicalLetter,,0,0,0,"Solriamfetol (Sunosi) for Excessive Daytime Sleepiness http://bit.ly/2HgWDkz #narcolepsy #sleepapnea",,,#narcolepsy #sleepapnea,1164885040871985153,https://twitter.com/MedicalLetter/status/1164885040871985153
2019-08-19 15:00:22,epocrates,,0,0,2,"#NewMonographMonday Sunosi (solriamfetol), approved for narcolepsy and obstructive sleep apnea http://bit.ly/33M3bkP",,,#NewMonographMonday,1163465738356699138,https://twitter.com/epocrates/status/1163465738356699138
2019-08-16 19:23:01,MedscapeCME,,0,0,0,"NOW LIVE: “Excessive Daytime Sleepiness in Clinical Practice: When Getting Enough Sleep Isn't Enough”- with Prof. Michael Thorpy of @EinsteinMed 11) What do you know about Solriamfetol? #MedscapeLIVE",,@EinsteinMed,#MedscapeLIVE,1162444669697056772,https://twitter.com/MedscapeCME/status/1162444669697056772
2019-08-11 12:01:43,banjanti,,0,0,0,"@JazzPharma Do you have any informations when you expect Solriamfetol will get a licence in EU?",,@JazzPharma,,1160521675856896000,https://twitter.com/banjanti/status/1160521675856896000
2019-08-09 08:06:45,SuperBobSaget,,0,0,2,"Wanted to shout out @JazzPharma for their focus in helping people like me that have EDS. I am very excited about your recent approval for solriamfetol! Proud of you! ",,@JazzPharma,,1159737767598927873,https://twitter.com/SuperBobSaget/status/1159737767598927873
2019-08-06 22:47:39,sleepattention,,0,0,0,"A new #medicine for #daytime_sleepiness was approved this year. Solriamfetol improved sleepiness in most patients with #narcolepsy and sleepy patients with obstructive #sleep_apnea. It blocks reuptake of dopamine and norepinephrine. http://bit.ly/sleep20190806",,,#medicine #daytime_sleepiness #narcolepsy #sleep_apnea,1158872291897483265,https://twitter.com/sleepattention/status/1158872291897483265
2019-08-06 10:39:33,SleepResearch_,,0,0,0,"Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor. https://ift.tt/2YLVBHf",,,,1158689059348340736,https://twitter.com/SleepResearch_/status/1158689059348340736
2019-08-05 16:23:22,noot_news,,0,0,0,"Solriamfetol Shows Efficacy in Treating Sleepiness, Impaired Wakefulness https://www.ajmc.com/newsroom/solriamfetol-shows-efficacy-in-treating-sleepiness-impaired-wakefulness via @AJMC_Journal",,@AJMC_Journal,,1158413193246470144,https://twitter.com/noot_news/status/1158413193246470144
2019-07-30 19:53:50,dtwResearchInc,,0,0,0,"Check out our primary research on sleep disorders! https://dtw.bz/SUNOSI #SUNOSI #JazzPharmaceuticals #dtwAwarenessStudy #AwarenessStudyResults #primaryResearch #solriamfetol #excessivesleepinesss #ES #sleepDisorders",,,#SUNOSI #JazzPharmaceuticals #dtwAwarenessStudy #AwarenessStudyResults #primaryResearch #solriamfetol #excessivesleepinesss #ES #sleepDisorders,1156291833770758144,https://twitter.com/dtwResearchInc/status/1156291833770758144
2019-07-12 19:23:07,TripPrimaryCare,,0,0,0,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1149761121986985984,https://twitter.com/TripPrimaryCare/status/1149761121986985984
2019-07-11 09:23:11,TripPrimaryCare,,0,0,0,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1149247755006750723,https://twitter.com/TripPrimaryCare/status/1149247755006750723
2019-07-08 19:21:31,tripdatabase,,0,0,0,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1148311168127250432,https://twitter.com/tripdatabase/status/1148311168127250432
2019-07-08 13:52:37,neurochecklists,,0,0,0,"A randomized study of solriamfetol for excessive sleepiness in narcolepsy ",,,,1148228398642278400,https://twitter.com/neurochecklists/status/1148228398642278400
2019-07-08 13:23:07,TripPrimaryCare,,0,0,0,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1148220970773204993,https://twitter.com/TripPrimaryCare/status/1148220970773204993
2019-07-06 23:23:07,TripPrimaryCare,,0,0,0,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1147647190799704064,https://twitter.com/TripPrimaryCare/status/1147647190799704064
2019-07-03 08:23:07,TripPrimaryCare,,0,0,0,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1146333535638380544,https://twitter.com/TripPrimaryCare/status/1146333535638380544
2019-07-02 01:21:30,tripdatabase,,0,0,0,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1145865044380573697,https://twitter.com/tripdatabase/status/1145865044380573697
2019-07-01 19:30:07,epocrates,,0,0,0,"#NewMonographMonday Check out the new Epocrates monograph for Sunosi (solriamfetol), approved for narcolepsy and obstructive sleep apnea (http://bit.ly/2LuJUxF).",,,#NewMonographMonday,1145776617140162561,https://twitter.com/epocrates/status/1145776617140162561
2019-07-01 03:23:07,TripPrimaryCare,,0,0,0,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1145533263223644160,https://twitter.com/TripPrimaryCare/status/1145533263223644160
2019-06-29 18:23:07,TripPrimaryCare,,0,0,0,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1145034978050355200,https://twitter.com/TripPrimaryCare/status/1145034978050355200
2019-06-28 06:23:07,TripPrimaryCare,,0,0,0,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1144491396285419520,https://twitter.com/TripPrimaryCare/status/1144491396285419520
2019-06-28 03:22:50,kittygalore57,,0,0,0,"@JazzPharma very excited to hear the solriamfetol has been approved for release. I tried xyrem but it made me retain fluid drastically, so hopefully I can take this.",,@JazzPharma,,1144446025941311489,https://twitter.com/kittygalore57/status/1144446025941311489
2019-06-26 15:01:07,atscommunity,,0,1,1,"Solriamfetol for excessive sleepiness in #OSA (TONES 3). A randomized controlled trial: https://www.atsjournals.org/doi/full/10.1164/rccm.201806-1100OC",,,#OSA,1143896979438809089,https://twitter.com/atscommunity/status/1143896979438809089
2019-06-26 12:21:30,tripdatabase,,0,1,1,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1143856814129328128,https://twitter.com/tripdatabase/status/1143856814129328128
2019-06-25 10:00:00,neurology_live,,0,2,1,"This week in headlines from #NNN: @JazzPharma's #solriamfetol scheduled, #ABO202, for infantile #Battendisease granted fast track, and study findings suggest that #neurofilament light in the CSF has multi-disease use as a biomarker.",,@JazzPharma,#NNN #solriamfetol #ABO202 #Battendisease #neurofilament,1143458814462701568,https://twitter.com/neurology_live/status/1143458814462701568
2019-06-25 09:23:07,TripPrimaryCare,,0,0,0,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1143449532757356548,https://twitter.com/TripPrimaryCare/status/1143449532757356548
2019-06-24 14:37:09,HealioPulm,,0,1,0,"Solriamfetol improves wakefulness, sleepiness in obstructive sleep apnea. #pulmonology #apnea #sleepdisorder",,,#pulmonology #apnea #sleepdisorder,1143166173141458949,https://twitter.com/HealioPulm/status/1143166173141458949
2019-06-23 20:23:06,TripPrimaryCare,,0,0,0,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1142890848323022853,https://twitter.com/TripPrimaryCare/status/1142890848323022853
2019-06-21 22:21:31,tripdatabase,,0,0,1,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1142195870013825026,https://twitter.com/tripdatabase/status/1142195870013825026
2019-06-20 15:30:00,neurology_live,,0,0,0,"Recently, @JazzPharma’s solriamfetol (#Sunosi), an FDA-approved therapy indicated to improve wakefulness in adults with excessive daytime sleepiness associated with #narcolepsy or #OSA, has been designated as a Schedule IV medication by the DEA.",,@JazzPharma,#Sunosi #narcolepsy #OSA,1141729922609664001,https://twitter.com/neurology_live/status/1141729922609664001
2019-06-20 15:06:46,PracticalNeuro,,0,0,0,"Schedule IV Designation For #Solriamfetol, a New Treatment for Excessive Daytime #Sleepiness in #Narcolepsy or OSA - Practical Neurology #Neurology #Sleep @JazzPharma",,@JazzPharma,#Solriamfetol #Sleepiness #Narcolepsy #Neurology #Sleep,1141724075024420866,https://twitter.com/PracticalNeuro/status/1141724075024420866
2019-06-19 11:23:07,TripPrimaryCare,,0,0,0,"New2Trip: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). Randomized Controlled Trial http://bit.ly/2WRxTnY",,,,1141305405064110080,https://twitter.com/TripPrimaryCare/status/1141305405064110080
2019-06-19 02:21:30,tripdatabase,,0,0,0,"New2Trip: Solriamfetol (Sunosi) - To treat excessive sleepiness in adult patients w/ narcolepsy or obstructive sleep apnea http://bit.ly/2QtyxXm",,,,1141169102314192896,https://twitter.com/tripdatabase/status/1141169102314192896
2019-06-18 20:32:00,neurology_live,,0,0,0,"#Solriamfetol (Sunosi, @JazzPharma) is expected to be available in July 2019 in the United States. https://www.neurologylive.com/clinical-focus/us-dea-designates-solriamfetol-as-schedule-iv-for-excessive-daytime-sleepiness-associated-with-narcolepsy-obstructive-sleep-apnea",,@JazzPharma,#Solriamfetol,1141081146479878144,https://twitter.com/neurology_live/status/1141081146479878144
2019-06-18 19:04:00,neurology_live,,0,0,0,"#Solriamfetol, the first and only FDA-approved dual-acting dopamine and norepinephrine reuptake inhibitor, will be commercially available in the United States in once-daily 75 mg and 150 mg tablets in July 2019. https://www.neurologylive.com/clinical-focus/us-dea-designates-solriamfetol-as-schedule-iv-for-excessive-daytime-sleepiness-associated-with-narcolepsy-obstructive-sleep-apnea",,,#Solriamfetol,1141059001171501056,https://twitter.com/neurology_live/status/1141059001171501056
2019-06-18 13:15:00,neurology_live,,0,0,0,"#ICYMI: @JazzPharma’s #solriamfetol has been adjusted to a Schedule IV medication by the DEA. Branded as #Sunosi, it's approved for improving wakefulness in adults with excessive daytime sleepiness associated with #narcolepsy or #OSA.",,@JazzPharma,#ICYMI #solriamfetol #Sunosi #narcolepsy #OSA,1140971171724218368,https://twitter.com/neurology_live/status/1140971171724218368
2019-06-18 01:15:35,SilasInman,,0,0,0,"Solriamfetol Receives Schedule IV Designation for Excessive Daytime Sleepiness in Narcolepsy, Obstructive Sleep Apnea https://www.neurologylive.com/clinical-focus/us-dea-designates-solriamfetol-as-schedule-iv-for-excessive-daytime-sleepiness-associated-with-narcolepsy-obstructive-sleep-apnea",,,,1140790125514936320,https://twitter.com/SilasInman/status/1140790125514936320
2019-06-17 21:53:00,neurology_live,,0,0,0,"#ICYMI: @JazzPharma’s #solriamfetol has been adjusted to a Schedule IV medication by the DEA. Branded as #Sunosi, it's approved for improving wakefulness in adults with excessive daytime sleepiness associated with #narcolepsy or #OSA. https://www.neurologylive.com/clinical-focus/us-dea-designates-solriamfetol-as-schedule-iv-for-excessive-daytime-sleepiness-associated-with-narcolepsy-obstructive-sleep-apnea",,@JazzPharma,#ICYMI #solriamfetol #Sunosi #narcolepsy #OSA,1140739142965350400,https://twitter.com/neurology_live/status/1140739142965350400
2019-06-17 18:09:24,PracticalNeuro,,0,0,0,"#Solriamfetol Efficacy and Safety for Treatment of Excessive Daytime #Sleepiness in People With #Narcolepsy or #OSA Is Consistent Across Trials - Practical Neurology #Neurology #SLEEP2019 @JazzPharma @StanfordMed",,@JazzPharma @StanfordMed,#Solriamfetol #Sleepiness #Narcolepsy #OSA #Neurology #SLEEP2019,1140682874645110785,https://twitter.com/PracticalNeuro/status/1140682874645110785
2019-06-17 17:50:00,neurology_live,,0,0,1,".@JazzPharma’s #solriamfetol (Sunosi), indicated for improving #wakefulness in adults with excessive daytime #sleepiness associated with #narcolepsy or obstructive sleep apnea, has been designated as a Schedule IV medication by the #DEA. https://www.neurologylive.com/clinical-focus/us-dea-designates-solriamfetol-as-schedule-iv-for-excessive-daytime-sleepiness-associated-with-narcolepsy-obstructive-sleep-apnea",,@JazzPharma,#solriamfetol #wakefulness #sleepiness #narcolepsy #DEA,1140677989996224513,https://twitter.com/neurology_live/status/1140677989996224513
2019-06-17 16:55:12,byMattHoffman,,0,0,0,"Looks like @JazzPharma’s #solriamfetol has been adjusted to a Schedule IV medication by the DEA. Branded as #Sunosi, it's approved for improving wakefulness in adults with excessive daytime sleepiness associated with #narcolepsy or #OSA. https://www.neurologylive.com/clinical-focus/us-dea-designates-solriamfetol-as-schedule-iv-for-excessive-daytime-sleepiness-associated-with-narcolepsy-obstructive-sleep-apnea",,@JazzPharma,#solriamfetol #Sunosi #narcolepsy #OSA,1140664200710295552,https://twitter.com/byMattHoffman/status/1140664200710295552
2019-06-17 14:02:59,Briefingcom,,0,0,0,"$JAZZ: Jazz Pharma announces that the DEA has designated solriamfetol (Sunosi) as a Schedule IV medicine http://bit.ly/2Fe0qOM",,,,1140620861243662336,https://twitter.com/Briefingcom/status/1140620861243662336
2019-06-17 12:24:04,mevansbrown,,0,4,3,"US DEA: Schedules of Controlled Substances: Placement of solriamfetol ((R)-2-amino-3-phenylpropyl carbamate) in Schedule IV. Interim final rule, with request for comments ",,,,1140595966560669697,https://twitter.com/mevansbrown/status/1140595966560669697
2019-06-14 12:00:23,prpnews,,0,0,0,"http://tinyurl.com/y2jftbtx Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea",,,,1139502841503125504,https://twitter.com/prpnews/status/1139502841503125504
2019-06-14 07:21:31,tripdatabase,,0,0,0,"New2Trip: Solriamfetol (Sunosi) - To treat excessive sleepiness in adult patients w/ narcolepsy or obstructive sleep apnea http://bit.ly/2QtyxXm",,,,1139432662412800002,https://twitter.com/tripdatabase/status/1139432662412800002
2019-06-13 15:07:08,MontefioreWake,,0,1,4,"Solriamfetol (Sunosi): New treatment for excessive daytime sleepiness in narcolepsy and sleep apnea should be available in a couple of months. ",,,,1139187451921084416,https://twitter.com/MontefioreWake/status/1139187451921084416
2019-06-12 17:11:21,luis_ortiz,,0,0,1,"One good benefit for solriamfetol: no effect on oral contraceptive effectiveness! #narcolepsy #SLEEP2019 #narcolepsynetwork #thepill",,,#narcolepsy #SLEEP2019 #narcolepsynetwork #thepill,1138856327097094145,https://twitter.com/luis_ortiz/status/1138856327097094145
2019-06-12 17:07:43,luis_ortiz,,0,0,0,"Solriamfetol appears to be a promising new treatment for #narcolepsy. Interestingly, type 2 narcolepsy appears to respond to lower doses than type 1 narcolepsy. #SLEEP2019 #narcolepsynetwork – at Henry B. Gonzalez Convention Center",,,#narcolepsy #SLEEP2019 #narcolepsynetwork,1138855408989134848,https://twitter.com/luis_ortiz/status/1138855408989134848
2019-06-08 18:31:56,efarisx2,,0,1,3,"EvidenceAlerts | Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial. https://www.evidencealerts.com/Social/Article/DePbEvaDMfpE_BA8qpSR7Q?Source=twitter#.XPv_ERtvaOM.twitter",,,,1137427052288782337,https://twitter.com/efarisx2/status/1137427052288782337
2019-06-08 18:16:48,SociedadGRAP,,0,1,1,"Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial. - PubMed - NCBI https://www.ncbi.nlm.nih.gov/pubmed/30521757/",,,,1137423245609709573,https://twitter.com/SociedadGRAP/status/1137423245609709573
2019-06-05 14:01:05,atscommunity,,0,0,2,"RT @ATSBlueEditor: Visual Abstract: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial http://ow.ly/7m8G50uvHEf @atscommunity",,@ATSBlueEditor @atscommunity,,1136271726369812480,https://twitter.com/atscommunity/status/1136271726369812480
2019-06-05 09:21:30,tripdatabase,,0,0,0,"New2Trip: Solriamfetol (Sunosi) - To treat excessive sleepiness in adult patients w/ narcolepsy or obstructive sleep apnea http://bit.ly/2QtyxXm",,,,1136201366500777989,https://twitter.com/tripdatabase/status/1136201366500777989
2019-06-04 11:49:00,pontepedrat,,0,0,1,"Solriamfetol Wins FDA Approval for Excessive Daytime Sleepiness in #Narcolepsy, Obstructive Sleep Apnea #OSA ⁦@SOGAPAR⁩",,@SOGAPAR,#Narcolepsy #OSA,1135876099756441600,https://twitter.com/pontepedrat/status/1135876099756441600
2019-06-03 20:36:50,ATSBlueEditor,,0,5,4,"Visual Abstract: Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3). A Randomized Controlled Trial http://ow.ly/7m8G50uvHEf @atscommunity",,@atscommunity,,1135646546882699270,https://twitter.com/ATSBlueEditor/status/1135646546882699270
2019-05-29 07:21:32,tripdatabase,,0,0,0,"New2Trip: Solriamfetol (Sunosi) - To treat excessive sleepiness in adult patients w/ narcolepsy or obstructive sleep apnea http://bit.ly/2QtyxXm",,,,1133634461344698368,https://twitter.com/tripdatabase/status/1133634461344698368
2019-05-28 14:08:48,SEMDocs,,0,0,1,"Narcolepsy patho: hypocretin deficiency in lateral hypothalamus cf: excessive daytime sleepiness, cataplexy, sleep paralysis, hypnagogic/hypnopompic hallucinations Inv: Polysomnography Modafinil +/- Ritalin/solriamfetol/TCAs Forced scheduled daily naps",,,,1133374565604839424,https://twitter.com/SEMDocs/status/1133374565604839424
2019-05-22 17:23:07,TripPrimaryCare,,0,0,0,"New2Trip: Randomized study of solriamfetol for excessive sleepiness in narcolepsy http://bit.ly/2L9FVbe",,,,1131249139650637831,https://twitter.com/TripPrimaryCare/status/1131249139650637831
2019-05-17 23:23:06,TripPrimaryCare,,0,0,0,"New2Trip: Randomized study of solriamfetol for excessive sleepiness in narcolepsy http://bit.ly/2L9FVbe",,,,1129527796395585543,https://twitter.com/TripPrimaryCare/status/1129527796395585543
2019-05-16 16:52:41,tripdatabase,,0,0,0,"New2Trip: Randomized study of solriamfetol for excessive sleepiness in narcolepsy http://bit.ly/2L9FVbe",,,,1129067153490153472,https://twitter.com/tripdatabase/status/1129067153490153472
2019-05-13 16:23:06,TripPrimaryCare,,0,0,0,"New2Trip: Randomized study of solriamfetol for excessive sleepiness in narcolepsy http://bit.ly/2L9FVbe",,,,1127972548417921025,https://twitter.com/TripPrimaryCare/status/1127972548417921025
2019-05-10 15:32:22,NancyFoldvaryDO,,0,4,14,"Proud to have presented @AAN on Solriamfetol Demonstrates Safety, Efficacy for Wakefulness in 1-Year Extension Trial #narcolepsy https://consultqd.clevelandclinic.org/solriamfetol-demonstrates-safety-efficacy-for-wakefulness-in-1-year-extension-trial/ via @CleClinicMD @WPSA1 @AOAforDOs #AANAM",,@AAN @CleClinicMD @WPSA1 @AOAforDOs,#narcolepsy #AANAM,1126872615761645569,https://twitter.com/NancyFoldvaryDO/status/1126872615761645569
2019-05-09 23:50:30,RichardW_1943,,0,0,0,"Solriamfetol Demonstrates Safety, Efficacy for Wakefulness in 1-Year Extension Trial https://consultqd.clevelandclinic.org/solriamfetol-demonstrates-safety-efficacy-for-wakefulness-in-1-year-extension-trial/ via @CleClinicMD",,@CleClinicMD,,1126635587245694977,https://twitter.com/RichardW_1943/status/1126635587245694977
2019-05-09 18:23:34,CleClinicMD,,2,1,3,"In the 2-week randomized withdrawal phase, patients switched to placebo had significantly worse scores on all 3 efficacy measures vs. those who remained on solriamfetol. #AANAM",,,#AANAM,1126553312147517443,https://twitter.com/CleClinicMD/status/1126553312147517443
2019-05-09 18:06:33,CleClinicMD,,3,5,6,"643 patients with narcolepsy or obstructive sleep apnea from 2 pivotal trials of solriamfetol participated in this 1-year open-label extension study with a 2-week withdrawal phase at the end. #AANAM",,,#AANAM,1126549029796634627,https://twitter.com/CleClinicMD/status/1126549029796634627
2019-05-06 01:51:31,tripdatabase,,0,0,0,"New2Trip: Randomized study of solriamfetol for excessive sleepiness in narcolepsy http://bit.ly/2L9FVbe",,,,1125216491790589953,https://twitter.com/tripdatabase/status/1125216491790589953
2019-05-04 22:23:07,TripPrimaryCare,,0,1,1,"New2Trip: Randomized study of solriamfetol for excessive sleepiness in narcolepsy http://bit.ly/2L9FVbe",,,,1124801655290126336,https://twitter.com/TripPrimaryCare/status/1124801655290126336
2019-05-02 10:24:44,TripPrimaryCare,,0,1,0,"New2Trip: Randomized study of solriamfetol for excessive sleepiness in narcolepsy http://bit.ly/2L9FVbe",,,,1123896092746231808,https://twitter.com/TripPrimaryCare/status/1123896092746231808
2019-04-30 21:21:30,tripdatabase,,0,0,0,"New2Trip: Randomized study of solriamfetol for excessive sleepiness in narcolepsy http://bit.ly/2L9FVbe",,,,1123336599410966528,https://twitter.com/tripdatabase/status/1123336599410966528
2019-04-28 16:23:06,TripPrimaryCare,,0,0,0,"New2Trip: Randomized study of solriamfetol for excessive sleepiness in narcolepsy http://bit.ly/2L9FVbe",,,,1122536730090004485,https://twitter.com/TripPrimaryCare/status/1122536730090004485
2019-04-27 20:01:08,DrScottHadland,,1,0,3,"@JessLynnMoreno Have been meaning to ask a smart pharmacist (eg, you) this: The new drug, solriamfetol, a DA and NE reuptake inhibitor for OSA/narcolepsy... Any suggestion it might be an agent similar to bupropion with antidepressant and/or addiction treatment properties?",,@JessLynnMoreno,,1122229210163097600,https://twitter.com/DrScottHadland/status/1122229210163097600
2019-04-25 16:00:01,MedscapePharm,,0,3,2,"This #OSA reference resource now includes @US_FDA approval of Solriamfetol, a dopamine/norepinephrine reuptake inhibitor that improves wakefulness in patients with excessive daytime sleepiness. http://ms.spr.ly/6018TGXmK",,@US_FDA,#OSA,1121443754064404487,https://twitter.com/MedscapePharm/status/1121443754064404487
2019-04-19 09:00:01,Medscape,,0,6,6,"This #OSA reference resource now includes @US_FDA approval of Solriamfetol, a dopamine/norepinephrine reuptake inhibitor that improves wakefulness in patients with excessive daytime sleepiness. http://ms.spr.ly/6010TGXm8",,@US_FDA,#OSA,1119163732922228740,https://twitter.com/Medscape/status/1119163732922228740
2019-04-17 17:00:20,FDA_Drug_Info,,1,4,1,"New! Drug Trials Snapshot available for Sunosi (solriamfetol): https://go.usa.gov/xmj3P.",,,,1118559833966436352,https://twitter.com/FDA_Drug_Info/status/1118559833966436352
2019-04-12 19:41:33,DrLyleBaker,,0,0,0,"5 New FDA Drugs: Single dose Baloxavir ($157) as effective as Tamiflu ($50). Shingrix ($140x2) preferred over live VZ virus for >50 y/o. Odactra is daily SL immunotherapy for dust mites, only modest efficacy. Solriamfetol for OSA. Aimovig ($575 month) inj monthly for migraine ppx ",,,,1116788466099081216,https://twitter.com/DrLyleBaker/status/1116788466099081216
2019-04-04 14:29:00,DynaMed_EBSCO,,0,0,0,"Solriamfetol recently @US_FDA approved for #narcolepsy. Find the evidence in DynaMed Plus: http://bit.ly/DM329-5",,@US_FDA,#narcolepsy,1113810707504685056,https://twitter.com/DynaMed_EBSCO/status/1113810707504685056
2019-04-02 07:03:11,amplia2mente,,0,0,0,"Sunosi (Solriamfetol Tablets) - new on RxList ",,,,1112973736221818880,https://twitter.com/amplia2mente/status/1112973736221818880
2019-03-29 23:23:01,Drug_Topics,,0,0,0,"Sunosi (solriamfetol) approved for excessive sleepiness in adults. http://bit.ly/2HVkuaS",,,,1111770770282344449,https://twitter.com/Drug_Topics/status/1111770770282344449
2019-03-27 17:47:55,MedicationMon,,0,1,0,"New drug #solriamfetol (#Sunosi) treats excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea https://apha.us/2Ua7swL",,,#solriamfetol #Sunosi,1110961659793813504,https://twitter.com/MedicationMon/status/1110961659793813504
2019-03-27 17:17:01,BernCartePharma,,0,0,0,"FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea ",,,,1110953886007939077,https://twitter.com/BernCartePharma/status/1110953886007939077
2019-03-27 14:39:00,MultiVuOnline,,0,0,0,"Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi™ (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea ",,,,1110914121225129985,https://twitter.com/MultiVuOnline/status/1110914121225129985
2019-03-26 16:18:52,Educated_Change,,0,0,0,"RT @PracticalNeuro: Practical Neurology - FDA Approves Solriamfetol for Treatment of Excessive Daytime #Sleepiness #Neurology #EDS #OSA @JazzPharma @US_FDA https://hubs.ly/H0h80ZH0",,@PracticalNeuro @JazzPharma @US_FDA,#Sleepiness #Neurology #EDS #OSA,1110576865616515072,https://twitter.com/Educated_Change/status/1110576865616515072
2019-03-26 15:10:06,PracticalNeuro,,0,0,0,"Practical Neurology - FDA Approves Solriamfetol for Treatment of Excessive Daytime #Sleepiness #Neurology #EDS #OSA @JazzPharma @US_FDA https://hubs.ly/H0h80ZH0",,@JazzPharma @US_FDA,#Sleepiness #Neurology #EDS #OSA,1110559556063629312,https://twitter.com/PracticalNeuro/status/1110559556063629312
2019-03-25 19:58:24,pharmacopsych,,0,0,2,"U.S. FDA has approved of solriamfetol (Sunosi; Jazz) for ""Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea."" Solriamfetol inhibits the dopamine (DAT) and norepinephrine (NET) transporters. https://investor.jazzpharma.com/node/16196/pdf",,,,1110269724385001474,https://twitter.com/pharmacopsych/status/1110269724385001474
2019-03-24 16:06:00,SpecialtyPTimes,,0,0,0,"Solriamfetol Approved for Excessive Daytime Sleepiness from Narcolepsy, Obstructive Sleep Apnea More: https://bit.ly/2JukCR5",,,,1109848849051348992,https://twitter.com/SpecialtyPTimes/status/1109848849051348992
2019-03-24 15:43:40,COSseaton,,0,0,0,"FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea ",,,,1109843231343169537,https://twitter.com/COSseaton/status/1109843231343169537
2019-03-23 11:52:29,medicaldialogs,,0,0,1,"Jazz Pharma gets USFDA nod to Solriamfetol to treat sleep disorder ",,,,1109422662789619713,https://twitter.com/medicaldialogs/status/1109422662789619713
2019-03-23 06:49:45,ATP_CME,,0,0,0,"Top story: FDA Approves Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or OSA - Sleep Review http://www.sleepreviewmag.com/2019/03/fda-approves-solriamfetol/, see more http://tweetedtimes.com/v/3400?s=tnp",,,,1109346476814155776,https://twitter.com/ATP_CME/status/1109346476814155776
2019-03-22 22:12:01,SleepReview,,0,4,4,"FDA Approves Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or OSA https://buff.ly/2upNsHH",,,,1109216184510173187,https://twitter.com/SleepReview/status/1109216184510173187
2019-03-22 22:00:20,medicalnewser,,0,0,0,"FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea...",,,,1109213243975835649,https://twitter.com/medicalnewser/status/1109213243975835649
2019-03-22 18:51:46,NarcolepsyZzzzz,,0,1,3,"#FDA Approves Once-Daily Solriamfetol (#Sunosi) for #Narcolepsy, #OSA: https://www.mdmag.com/medical-news/fda-approves-oncedaily-sunosi-for-narcolepsy-osa-patients #sleep #medicine #science #research #news",,,#FDA #Sunosi #Narcolepsy #OSA #sleep #medicine #science #research #news,1109165792782893056,https://twitter.com/NarcolepsyZzzzz/status/1109165792782893056
2019-03-22 16:38:06,MDEdgeTweets,,0,5,2,"#FDAapproval: The Food and Drug Administration has approved solriamfetol (#Sunosi), the first #dopamine and #norepinephrine reuptake inhibitor for the treatment of excessive daytime sleepiness in patients with #narcolepsy or obstructive sleep apnea. #hcsm",,,#FDAapproval #Sunosi #dopamine #norepinephrine #narcolepsy #hcsm,1109132153420505088,https://twitter.com/MDEdgeTweets/status/1109132153420505088
2019-03-22 15:28:43,PharmaNewsUSA,,0,0,1,"Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi™ (solriamfetol) ",,,,1109114692293795840,https://twitter.com/PharmaNewsUSA/status/1109114692293795840
2019-03-22 14:56:41,terraziporyn,,0,0,0,"FDA Approves Once-Daily Solriamfetol for Narcolepsy, OSA http://www.mdmag.com/medical-news/fda-approves-oncedaily-sunosi-for-narcolepsy-osa-patients?fbclid=IwAR3K-YlTuP6F7PC_Ox7CK2p8paslDymTIGZBXL9qau13eBd7R6Ho78jYFao via @mdmagazine #sleepmatters",,@MDMagazine,#sleepmatters,1109106631047086081,https://twitter.com/terraziporyn/status/1109106631047086081
2019-03-22 13:44:00,Physns1stWatch,,0,2,4,"The FDA has approved solriamfetol (Sunosi) to treat excessive daytime sleepiness in adults with #narcolepsy or obstructive sleep #apnea.",,,#narcolepsy #apnea,1109088338185781249,https://twitter.com/Physns1stWatch/status/1109088338185781249
2019-03-22 13:15:07,ASHPOfficial,,0,0,0,"Solriamfetol was recently approved by the FDA for the treatment of excessive sleepiness in adult patients with #narcolepsy or obstructive #sleepapnea. Scheduling of this medication is pending by the DEA. Read more:",,,#narcolepsy #sleepapnea,1109081068169318400,https://twitter.com/ASHPOfficial/status/1109081068169318400
2019-03-22 11:05:15,PlexusVentures,,0,0,0,"#JazzPharma's #sleepdisorder treatment gets #FDA nod https://finance.yahoo.com/news/jazz-pharmas-sleep-disorder-treatment-000229518.html?soc_src=social-sh&amp;soc_trk=tw via @YahooFinance @JazzPharma #solriamfetol #narcolepsy #sleepapnea #OSA",,@YahooFinance @JazzPharma,#JazzPharma #sleepdisorder #FDA #solriamfetol #narcolepsy #sleepapnea #OSA,1109048386861363201,https://twitter.com/PlexusVentures/status/1109048386861363201
2019-03-22 06:59:08,Pharmashot,,0,0,0,"Jazz Pharmaceuticals’ Sunosi (solriamfetol) Receives FDA’s Approval for the Treatment of Sleep Disorders @JazzPharma https://pharmashots.com/2019/03/22/%EF%BB%BFjazz-pharmaceuticals-sunosi-solriamfetol-receives-fdas-approval-for-the-treatment-of-sleep-disorders/",,@JazzPharma,,1108986449607585792,https://twitter.com/Pharmashot/status/1108986449607585792
2019-03-21 23:35:42,ausdisltd,,0,0,0,"The US Food and Drug Administration (FDA) has approved solriamfetol (Sunosi, Jazz Pharmaceuticals) to improve wakefulness in adults with excessive daytime sleepiness associated with #Narcolepsy or obstructive sleep apnea (OSA).",,,#Narcolepsy,1108874856236531712,https://twitter.com/ausdisltd/status/1108874856236531712
2019-03-21 22:18:01,MedicalLetter,,0,0,3,"The approval of Sunosi (solriamfetol) got us thinking about other drugs we've reviewed for narcolepsy. Here's our review of modafinil from 20 years ago. #TBT Our review of solriamfetol will use the peer-reviewed, consensus-based, objective process we've relied on for 60 years ",,,#TBT,1108855308120657920,https://twitter.com/MedicalLetter/status/1108855308120657920
2019-03-21 17:23:00,BioPharmaDive,,0,0,2,"Solriamfetol, a treatment for excessive daytime sleepiness in adults with narcolepsy or obstructive sleep apnea, should launch in mid-2019, $JAZZ said",,,,1108781063139020801,https://twitter.com/BioPharmaDive/status/1108781063139020801
2019-03-21 17:09:36,MedicalLetter,,0,0,0,"FDA approves Sunosi (solriamfetol) for excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea. First dopamine and norepinephrine reuptake inhibitor (DNRI). Will have to wait for DEA scheduling to launch https://bit.ly/2JsTdyJ",,,,1108777691342430208,https://twitter.com/MedicalLetter/status/1108777691342430208
2019-03-21 15:43:59,marclefrancois4,,0,0,0,"FDA Approves Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or OSA https://www.marclefrancois.net/2019/03/21/fda-approves-solriamfetol-for-excessive-daytime-sleepiness-associated-with-narcolepsy-or-osa/",,,,1108756146096095234,https://twitter.com/marclefrancois4/status/1108756146096095234
2019-03-21 15:11:22,BrainSightsApp,,0,0,0,"FDA Clears Solriamfetol (Sunosi) for Narcolepsy, OSA - Medscape - Neurology via BrainSights http://www.medscape.com/viewarticle/910723?src=rss",,,,1108747936148717568,https://twitter.com/BrainSightsApp/status/1108747936148717568
2019-03-21 14:55:30,SilasInman,,0,1,0,"Solriamfetol Wins FDA Approval for Excessive Daytime Sleepiness in Narcolepsy, Obstructive Sleep Apnea ",,,,1108743942877655046,https://twitter.com/SilasInman/status/1108743942877655046
2019-03-21 14:39:42,behavenet,,0,0,0,"Sunosi brand solriamfetol approved for promoting wakefulness https://behavenet.com/sunosi",,,,1108739967902195712,https://twitter.com/behavenet/status/1108739967902195712
2019-03-21 14:35:23,drhatton,,0,0,0,"#FDAapproves #Sunosi (#solriamfetol) for narcolepsy or obstructive sleep apnea. Do you know how to say the generic name? Sol-rih-AM-fuh-tawl #PROnounce #ProDataHealth #pronunciation",,,#FDAapproves #Sunosi #solriamfetol #PROnounce #ProDataHealth #pronunciation,1108738880537325569,https://twitter.com/drhatton/status/1108738880537325569
2019-03-21 14:34:57,samehserry20,,0,3,6,"Great news -Solriamfetol Wins FDA Approval for Excessive Daytime Sleepiness in Narcolepsy, Obstructive Sleep Apnea http://www.neurologylive.com/clinical-focus/solriamfetol-fda-approval-excessive-daytime-sleepiness-narcolepsy-obstructive-sleep-apnea?utm_medium=email via @neurology_live",,@neurology_live,,1108738773309894657,https://twitter.com/samehserry20/status/1108738773309894657
2019-03-21 14:25:11,aliciabigica,,0,0,0,"@US_FDA approves #solriamfetol for daytime sleepiness in #narcolepsy #obstructivesleepapnea from @JazzPharma https://www.neurologylive.com/clinical-focus/solriamfetol-fda-approval-excessive-daytime-sleepiness-narcolepsy-obstructive-sleep-apnea",,@US_FDA @JazzPharma,#solriamfetol #narcolepsy #obstructivesleepapnea,1108736315649073152,https://twitter.com/aliciabigica/status/1108736315649073152
2019-03-21 14:19:02,neurology_live,,0,2,2,"The US #FDA has approved solriamfetol (Sunosi, @JazzPharma) for the treatment of excessive daytime sleepiness in adults with #narcolepsy or obstructive sleep apnea. https://www.neurologylive.com/clinical-focus/solriamfetol-fda-approval-excessive-daytime-sleepiness-narcolepsy-obstructive-sleep-apnea",,@JazzPharma,#FDA #narcolepsy,1108734767292395521,https://twitter.com/neurology_live/status/1108734767292395521
2019-03-21 12:12:09,Briefingcom,,0,0,0,"$JAZZ: Jazz Pharma announces FDA approval of Sunosi (solriamfetol) to improve wakefulness in adult patients with... http://bit.ly/2TlHyl9",,,,1108702836949286912,https://twitter.com/Briefingcom/status/1108702836949286912
2019-03-21 05:25:49,Consumer__Watch,,0,0,0,"FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea ",,,,1108600577343307776,https://twitter.com/Consumer__Watch/status/1108600577343307776
2019-03-21 04:28:14,TheKoreaHerald,,0,0,1,"#SKBiopharmaceuticals marks first #FDA approval #sunosi #solriamfetol ",,,#SKBiopharmaceuticals #FDA #sunosi #solriamfetol,1108586087520178176,https://twitter.com/TheKoreaHerald/status/1108586087520178176
2019-03-21 04:08:48,SportSleepDoc,,0,0,0,"It looks like #narcolepsy patients have a new option! @JazzPharma #Sunosi #JZP110 #solriamfetol ",,@JazzPharma,#narcolepsy #Sunosi #JZP110 #solriamfetol,1108581197150601216,https://twitter.com/SportSleepDoc/status/1108581197150601216
2019-03-21 03:33:30,Shailesh_Kumars,Reuters,0,0,1,"Wait what - same drug solriamfetol will work for OSA and Narcolepsy. This doesn’t sound right; these are very different sleep disorders.",,,,1108572313807736832,https://twitter.com/Shailesh_Kumars/status/1108572313807736832
2019-03-21 01:27:34,drrickbarnett,,0,0,0,"FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness (EDS) Assoc w/Narcolepsy or Obstructive Sleep Apnea. It’s the “1st dual-acting dopamine+norepinephrine reuptake inhibitor(DNRI) approved to treat EDS in adults living w/ narcolepsy or OSA. ",,,,1108540622145753090,https://twitter.com/drrickbarnett/status/1108540622145753090
2019-03-21 01:22:00,MedPipeline,,0,0,0,"FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea ",,,,1108539221625720833,https://twitter.com/MedPipeline/status/1108539221625720833
2019-03-21 00:52:42,DrugscomNew,,0,0,1,"FDA Approves #Sunosi (solriamfetol) for Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea - ",,,#Sunosi,1108531848785903616,https://twitter.com/DrugscomNew/status/1108531848785903616
2019-03-21 00:52:42,Drugscom,,0,4,7,"FDA Approves #Sunosi (solriamfetol) for Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea - ",,,#Sunosi,1108531847603150849,https://twitter.com/Drugscom/status/1108531847603150849
2019-03-21 00:44:42,drfranktarazi,,0,0,2,"Another day, another drug approval! After $SAGE #Zulrusso for #Postpartum #Depression, #FDA approves $JAZZ #Sunosi™ (solriamfetol) for Excessive Daytime Sleepiness Associated with #Narcolepsy or Obstructive #Sleep #Apnea!",,,#Zulrusso #Postpartum #Depression #FDA #Sunosi #Narcolepsy #Sleep #Apnea,1108529832915279872,https://twitter.com/drfranktarazi/status/1108529832915279872
2019-03-21 00:02:12,CristinNara,,0,0,0,"$JAZZ's Sunosi (solriamfetol) finally nabs that approval. first comments from Bruce Cozadd on @TheTerminal",,@TheTerminal,,1108519136328642562,https://twitter.com/CristinNara/status/1108519136328642562
2019-03-20 23:52:01,fdadaily,,0,0,0,"Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi™ (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea, ,https://fdadaily.com/2019/03/20/jazz-pharmaceuticals-announces-u-s-fda-approval-of-sunosi-solriamfetol-for-excessive-daytime-sleepiness-associated-with-narcolepsy-or-obstructive-sleep-apnea/",,,,1108516577002078208,https://twitter.com/fdadaily/status/1108516577002078208
2019-03-20 23:46:22,FN_News_en,,0,0,0,"Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi (solriamfetol) for Excessive Daytime Sleepiness Ass https://www.finanznachrichten.de/nachrichten-2019-03/46259546-jazz-pharmaceuticals-announces-u-s-fda-approval-of-sunosi-solriamfetol-for-excessive-daytime-sleepiness-associated-with-narcolepsy-or-obstructive-s-008.htm",,,,1108515154780655616,https://twitter.com/FN_News_en/status/1108515154780655616
2019-03-20 23:45:09,CrweWorld,,0,0,0,"Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi™ (solriamfetol) for Excessive Daytime Sleepiness Associ http://crweworld.com/article/news-provided-by-pr-newswire/1023995/jazz-pharmaceuticals-announces-us-fda-approval-of-sunosi-solriamfetol-for-excessive-daytime-sleepiness-associated-with-narcolepsy-or-obstructive-sleep-apnea",,,,1108514848789282816,https://twitter.com/CrweWorld/status/1108514848789282816
2019-03-20 23:29:01,Trade_The_News,,0,2,1,"$JAZZ U.S. FDA approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea (Jazz Pharmaceuticals) (More at https://www.tradethenews.com/?twtId=6994)",,,,1108510789110022144,https://twitter.com/Trade_The_News/status/1108510789110022144
2019-03-20 23:13:44,RazzleTazzleMag,,0,0,0,"Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi™ (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea http://razzletazzle.com/showbiz-rightnow/jazz-pharmaceuticals-announces-u-s-fda-approval-of-sunosi-solriamfetol-for-excessive-daytime-sleepiness-associated-with-narcolepsy-or-obstructive-sleep-apnea/2019/03/20/",,,,1108506942798991361,https://twitter.com/RazzleTazzleMag/status/1108506942798991361
2019-03-20 23:07:19,gcassidy718,,0,0,0,"Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi(TM) (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea. $JAZZ https://blueequity.io/r/25290",,,,1108505326972620801,https://twitter.com/gcassidy718/status/1108505326972620801
2019-03-20 23:03:43,pharminews,,0,1,3,"Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi(TM) (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea - http://zpr.io/ghkni #pharma #news",,,#pharma #news,1108504418880835585,https://twitter.com/pharminews/status/1108504418880835585
2019-03-20 23:00:57,marketcheetah,,0,0,0,"Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi™ (solriamfetol) for Excessive Daytime Sleepiness A https://marketcheetah.com/2019/03/20/jazz-pharmaceuticals-announces-u-s-fda-approval-of-sunosi-solriamfetol-for-excessive-daytime-sleepiness-associated-with-narcolepsy-or-obstructive-sleep-apnea/?utm_campaign=twitter&amp;utm_medium=twitter&amp;utm_source=twitter",,,,1108503723326783488,https://twitter.com/marketcheetah/status/1108503723326783488
2019-03-19 04:50:02,EurekaMag,,0,2,0,"A Randomized Study of Solriamfetol for Excessive Sleepiness in Narcolepsy http://dlvr.it/R15r95 #eurekamag",,,#eurekamag,1107866799020765184,https://twitter.com/EurekaMag/status/1107866799020765184
2019-03-17 12:48:14,drfranktarazi,BioStocks,0,0,0,"A busy week ahead for #Biotechs! $SAGE and $JAZZ are waiting for #FDA decision on #Brexnanolone and #Solriamfetol (JZP-110). ",,,#Biotechs #FDA #Brexnanolone #Solriamfetol,1107262365115006976,https://twitter.com/drfranktarazi/status/1107262365115006976
2019-03-14 07:53:07,Renal_Bio,,0,1,0,"SingleDose Pharmacokinetics and Safety of Solriamfetol in Participants With Normal or Impaired Renal Function and With EndStage Renal Disease Requiring Hemodialysis.: Solriamfetol JZP110 a selective dopamine and norepinephrine… http://bioportfol.io/R0p3DW #renalcell #kidneycancer",,,#renalcell #kidneycancer,1106100931337175040,https://twitter.com/Renal_Bio/status/1106100931337175040
2019-03-12 05:48:05,Sleep_Bio,,0,1,0,"Solriamfetol in Improving Sleep in Patients With Grade IIIV Glioma http://bioportfol.io/R0fKt3 #sleep",,,#sleep,1105344692743368704,https://twitter.com/Sleep_Bio/status/1105344692743368704
2019-03-03 22:46:33,semodough,,0,0,3,"$JAZZ expects Phase II data in for Solriamfetol in Parkinson's for excessive sleepiness. The PDUFA for Solriamfetol in Excessive Sleepiness (ES) in Obstructive Sleep and Apnea (OSA) has been rescheduled to 3.20.19.",,,,1102339505250537472,https://twitter.com/semodough/status/1102339505250537472
2019-02-22 18:08:51,accpchest,,0,2,2,"Solriamfetol improves sleepiness and sleep latency in patients with obstructive sleep apnea. Visual abstract by Dr. Yonatan Greenstein. https://hubs.ly/H0gGwPW0",,,,1099008128224514048,https://twitter.com/accpchest/status/1099008128224514048
2019-02-14 20:10:34,semodough,,0,3,7,"3/11: PDUFA: $REGN, Dupixent, adolescent atopic dermatitis 3/19: PDUFA: $SAGE, Zulresso, postpartum depression 3/20: PDUFA: $JAZZ, Solriamfetol (wake promoting agent; excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea)",,,,1096139659829219328,https://twitter.com/semodough/status/1096139659829219328
2019-02-13 21:26:01,BioWorld,,1,1,2,"Adults with narcolepsy could gain two new treatments this year: @JazzPharma's solriamfetol and Harmony Bioscience's pitolisant, the NDA for which is now under priority review at FDA. Solriamfetol's PDUFA date is March 20. Pitolisant, approved in Europe, could clear FDA this year.",,@JazzPharma,,1095796257694466048,https://twitter.com/BioWorld/status/1095796257694466048
2019-02-13 20:36:59,semodough,,0,0,1,"Stifel $JAZZ Heme-Onc franchise is rebuilding,continued effort to unlock Vyxeos potential&amp;look forward to solriamfetol PDUFA (3/20/19)JZP-258 Phase 3 narcolepsy data (Spring 2019) lower our Target Price to $180 without Erwinaze revenues 2021 and beyond.",,,,1095783916982673409,https://twitter.com/semodough/status/1095783916982673409
2019-02-13 18:07:44,accpchest,,0,3,4,"Solriamfetol improves sleepiness and sleep latency in patients with obstructive sleep apnea. Visual abstract by Dr. Yonatan Greenstein. https://hubs.ly/H0gtjsn0",,,,1095746357917335553,https://twitter.com/accpchest/status/1095746357917335553
2019-02-05 01:07:32,saniom1,,0,0,0,"Solriamfetol, a selective dopamine/norepi reuptake inhibitor, effective for the treatment of Excessive Sleepiness in OSA. ",,,,1092590514099105798,https://twitter.com/saniom1/status/1092590514099105798
2019-01-31 23:59:18,genphys,,0,0,0,"Safety and efficacy of solriamfetol in narcolepsy | Annals of Neurology - MD Linx - +GENERAL PHYSICS LABORATORY (GPL) Safety and efficacy of solriamfetol in narcolepsy | Annals of Neurology MD LinxNeurology Article: A randomized ... https://www.genphys.com/science-news/safety-and-efficacy-of-solriamfetol-in-narcolepsy-annals-of-neurology-md-linx",,,,1091123792049389568,https://twitter.com/genphys/status/1091123792049389568
2019-01-30 15:58:01,StanfordPSY,,0,0,3,"Jed Black with @StanfordPSY's Division of Sleep Medicine &amp; colleagues found that solriamfetol ""significantly increased wakefulness &amp; reduced sleepiness in participants with obstructive sleep apnea (#OSA) &amp; excessive sleepiness."" http://bit.ly/2RI2kP9",,@StanfordPSY,#OSA,1090640282041880577,https://twitter.com/StanfordPSY/status/1090640282041880577
2019-01-30 09:26:52,NatRevNeurol,,0,0,0,"Solriamfetol shows promise for treating excessive sleepiness in people with narcolepsy ",,,,1090541847913603073,https://twitter.com/NatRevNeurol/status/1090541847913603073
2019-01-29 18:46:59,MyNeuroNewscom,,0,0,0,"(A Randomized Study of Solriamfetol for Excessive Sleepiness in Narcolepsy) has been published on MyNeuroNews - https://myneuronews.com/uncategorized/a-randomized-study-of-solriamfetol-for-excessive-sleepiness-in-narcolepsy/",,,,1090320416068042753,https://twitter.com/MyNeuroNewscom/status/1090320416068042753
2019-01-25 15:49:00,StanfordPSY,,0,0,1,"Randomized controlled trial evaluating solriamfetol for excessive sleepiness in #OSA --&gt; http://bit.ly/2RI2kP9 Study published by Jed Black w/@StanfordPSY's Division of Sleep Medicine &amp; colleagues in American Journal of Respiratory &amp; Critical Care Medicine (@atsblueeditor)!",,@StanfordPSY @ATSBlueEditor,#OSA,1088826076254666752,https://twitter.com/StanfordPSY/status/1088826076254666752
2019-01-24 15:10:21,clinthe,,0,0,0,"#therapeutics #clinicaltrials Does eating affect the pharmacokinetics or bioavailability of solriamfetol? http://ow.ly/4mgg30nnVp0",,,#therapeutics #clinicaltrials,1088453960065703936,https://twitter.com/clinthe/status/1088453960065703936
2019-01-18 23:35:04,prpnews,,0,0,0,"http://tinyurl.com/ybg2644m Jazz Pharmaceuticals Receives New PDUFA Goal Date for Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea",,,,1086406650204966912,https://twitter.com/prpnews/status/1086406650204966912
2019-01-07 19:37:00,neurology_live,,0,0,1,"ICYMI on Neurology News Network: The FDA's decision to delay the review of solriamfetol's NDA, a conversation with the director of clinical trials at the @UF Center for Movement Disorders and Neurorestoration, and a migraine #PeerExchange.",,@UF,#PeerExchange,1082360471519342592,https://twitter.com/neurology_live/status/1082360471519342592
2019-01-06 18:24:00,neurology_live,,0,0,1,"#ICYMI on this week on Neurology News Network: The FDA's decision to delay the review of solriamfetol's NDA, a conversation with the director of clinical trials at the @UF Center for Movement Disorders and Neurorestoration, and a migraine #PeerExchange. https://www.neurologylive.com/videos/solriamfetol-pdufa-date-pushed-recognizing-parkinson-disease-chronic-migraine-peer-exchange-program",,@UF,#ICYMI #PeerExchange,1081979712610725888,https://twitter.com/neurology_live/status/1081979712610725888
2019-01-05 13:37:00,neurology_live,,0,1,2,"This week on Neurology News Network: The FDA's decision to delay the review of solriamfetol's NDA, a conversation with the director of clinical trials at the @UF Center for Movement Disorders and Neurorestoration, and a migraine #PeerExchange. https://www.neurologylive.com/videos/solriamfetol-pdufa-date-pushed-recognizing-parkinson-disease-chronic-migraine-peer-exchange-program",,@UF,#PeerExchange,1081545098741989376,https://twitter.com/neurology_live/status/1081545098741989376
2019-01-03 03:31:46,LucasMDonovan,suzeber,0,0,0,"Of course Dr. Bertisch! It’s an editorial related to the recent Solriamfetol trial.",,,,1080668011646705665,https://twitter.com/LucasMDonovan/status/1080668011646705665
2019-01-02 19:59:00,neurology_live,,0,1,1,"#ICYMI: Solriamfetol, an investigational agent for the improvement of wakefulness and reduction of excessive daytime sleepiness in adults with narcolepsy or OSA, has had its PDUFA goal date extended an additional 3 months, to March 20, 2019 ",,,#ICYMI,1080554068408320001,https://twitter.com/neurology_live/status/1080554068408320001
2019-01-01 10:27:05,accesspage,,0,0,0,"The US Food and Drug Administration (FDA) has extended the review period for Jazz Pharmaceuticals plc’s new drug application (NDA) for solriamfetol as a treatment to improve wakefulness and reduce excessive daytime sleepiness in adult patients http://rspec.io/r/1026cbeC478528",,,,1080047752371818497,https://twitter.com/accesspage/status/1080047752371818497
2018-12-31 00:39:59,lbfwolfe,,0,1,2,"Interesting paper- Vishesh Kapur highlighting - We have more tools to treat sleepiness in OSA (EX: Solriamfetol), we need a framework to understand when to initiate alerting medications ( AJRCCM Articles in Press. Published on 27-December-2018 as 10.1164/rccm.201812-2291ED ) ",,,,1079537615869800449,https://twitter.com/lbfwolfe/status/1079537615869800449
2018-12-28 21:34:33,clinthe,,0,1,0,"A Phase I, Randomized, Crossover, Open-Label Study of the Pharmacokinetics of Solriamfetol (JZP-110) in Healthy Adult Subjects With and Without Food http://dlvr.it/QvYKWj",,,,1078766175142608897,https://twitter.com/clinthe/status/1078766175142608897
2018-12-28 16:13:01,neurology_live,,0,0,1,"#ICYMI: Solriamfetol, an investigational agent for the improvement of wakefulness and reduction of excessive daytime sleepiness in adults with narcolepsy or OSA, has had its PDUFA goal date extended an additional 3 months, to March 20, 2019. https://www.neurologylive.com/clinical-focus/fda-pushes-back-solriamfetol-pdufa-date-for-excessive-sleepiness",,,#ICYMI,1078685258768277505,https://twitter.com/neurology_live/status/1078685258768277505
2018-12-27 15:12:00,byMattHoffman,,0,1,1,"For those of you who were excited to see #solriamfetol enter the market for excessive sleepiness in OSA and narcolepsy, it looks like you'll have to wait until the new year (and by that I mean March). ",,,#solriamfetol,1078307515706810368,https://twitter.com/byMattHoffman/status/1078307515706810368
2018-12-27 15:02:00,neurology_live,,0,0,1,"Solriamfetol, an investigational agent for the improvement of wakefulness and reduction of excessive daytime sleepiness in adults with narcolepsy or OSA, has had its PDUFA goal date extended an additional 3 months, to March 20, 2019. https://www.neurologylive.com/clinical-focus/fda-pushes-back-solriamfetol-pdufa-date-for-excessive-sleepiness",,,,1078304999241859073,https://twitter.com/neurology_live/status/1078304999241859073
2018-12-26 22:05:06,medicalnewser,,0,0,0,"Jazz Pharmaceuticals Receives New PDUFA Goal Date for Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea...",,,,1078049089458196481,https://twitter.com/medicalnewser/status/1078049089458196481
2018-12-24 13:49:41,PricentricALSCG,,0,0,0,"Jazz Pharmaceuticals Receives New PDUFA Goal Date for Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea http://investor.jazzpharma.com/phoenix.zhtml?c=210227&amp;p=RssLanding&amp;cat=news&amp;id=2381466",,,,1077199636996210688,https://twitter.com/PricentricALSCG/status/1077199636996210688
2018-12-22 05:40:18,genphys,,0,0,0,"Solriamfetol Feasible for Sleep Apnea-Related Tiredness - Neurology Advisor - +GENERAL PHYSICS LABORATORY (GPL) Solriamfetol Feasible for Sleep Apnea-Related Tiredness Neurology AdvisorSolriamfetol therapy, compared with placebo, ... https://www.genphys.com/science-news/solriamfetol-feasible-for-sleep-apnea-related-tiredness-neurology-advisor",,,,1076351702180057088,https://twitter.com/genphys/status/1076351702180057088
2018-12-21 21:32:40,MaisaCorp,,0,0,0,"$JAZZ FDA extended the review period for the company's solriamfetol drug candidate by three months so it can better examine proposed labeling for the experimental nacrolepsy treatment.",,,,1076228988799016965,https://twitter.com/MaisaCorp/status/1076228988799016965
2018-12-21 16:20:31,jq1234t,TerryMSmith,2,0,0,"Solriamfetol delay PR doesn’t sound like FDA related, more like major changes made by $JAZZ either to draft label or additional “data” submitted to support draft label.",,,,1076150433058574336,https://twitter.com/jq1234t/status/1076150433058574336
2018-12-21 15:51:10,TerryMSmith,AlpineBV_Miller,2,0,0,"I think David is right. Delayed solriamfetol this morning.",,,,1076143043596730368,https://twitter.com/TerryMSmith/status/1076143043596730368
2018-12-21 14:03:44,financialbuzz,,0,0,0,"Jazz Pharmaceuticals Receives New PDUFA Goal Date for Solriamfetol for Excessive Daytime Sleepiness Associated w.. ",,,,1076116008727851010,https://twitter.com/financialbuzz/status/1076116008727851010
2018-12-21 14:02:38,Briefingcom,,0,0,0,"$JAZZ: Jazz Pharma receives new PDUFA goal date for Solriamfetol for excessive daytime sleepiness associated with... http://bit.ly/2PRWHZD",,,,1076115733417869312,https://twitter.com/Briefingcom/status/1076115733417869312
2018-12-21 13:42:27,HottestStockNow,,0,0,0,"FDA Extends Review Period for $JAZZ 's NDA for Solriamfetol for Excessive Daytime Sleepiness http://crweworld.com/symbol/JAZZ",,,,1076110653780185089,https://twitter.com/HottestStockNow/status/1076110653780185089
2018-12-21 13:20:53,DrZoroufy,,0,0,1,"Solriamfetol review by the FDA was postponed to March, 2019. (Solriamfetol is a stimulant for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea) #sleepapnea #narcolepsy ⁦@JazzPharma⁩ https://finance.yahoo.com/news/jazz-pharmaceuticals-receives-pdufa-goal-120000691.html",,@JazzPharma,#sleepapnea #narcolepsy,1076105226359205888,https://twitter.com/DrZoroufy/status/1076105226359205888
2018-12-21 12:59:04,CrweWorld,,0,0,0,"Jazz Pharmaceuticals Receives New PDUFA Goal Date for Solriamfetol for Excessive Daytime Sleepiness Associated with http://crweworld.com/article/news-provided-by-pr-newswire/919465/jazz-pharmaceuticals-receives-new-pdufa-goal-date-for-solriamfetol-for-excessive-daytime-sleepiness-associated-with-narcolepsy-or-obstructive-sleep-apnea",,,,1076099734392066048,https://twitter.com/CrweWorld/status/1076099734392066048
2018-12-21 12:57:24,CorpHano,,0,0,0,"Jazz Pharmaceuticals Receives New PDUFA Goal Date for Solriamfetol for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea http://bit.ly/2GxrtaX",,,,1076099313967747072,https://twitter.com/CorpHano/status/1076099313967747072
2018-12-21 12:17:58,DonnaYoungDC,,0,0,0,"$JAZZ says #FDA has extended the review period by 3 months for NDA for solriamfetol to improve wakefulness/reduce excessive daytime sleepiness in adults w/ narcolepsy or obstructive sleep apnea; New PDUFA March 20, 2019. https://finance.yahoo.com/news/jazz-pharmaceuticals-receives-pdufa-goal-120000691.html #pharma #biotech",,,#FDA #pharma #biotech,1076089394040356866,https://twitter.com/DonnaYoungDC/status/1076089394040356866
2018-12-21 12:03:11,BioStocks,,0,1,0,"$JAZZ FDA Extends Review Period for NDA for Solriamfetol by 3 Months. New PDUFA 03/20/19",,,,1076085673730412545,https://twitter.com/BioStocks/status/1076085673730412545
2018-12-19 11:39:11,semodough,,0,0,0,"BMO $JAZZ being more conservative with acceleration of Vyxeos&amp;Erwinaze,Solriamfetol launch curve (PDUFA this Thursday), although are more aggressive with Xyrem/JZP-258. also assuming a more significant investment year in 2019, partially offset by a share repo in 4Q18. PT to 199",,,,1075354855353532417,https://twitter.com/semodough/status/1075354855353532417
2018-12-17 19:34:31,drugnewsin,,0,0,0,"Solriamfetol Feasible for Sleep Apnea-Related Tiredness - http://www.drugnews.in/2018/12/17/solriamfetol-feasible-for-sleep-apnea-related-tiredness/",,,,1074749702908887040,https://twitter.com/drugnewsin/status/1074749702908887040
2018-12-17 02:20:32,semodough,,0,0,2,"#FDA 2/17-18: FDA AdCom: Joint Mtg of Anesthetic &amp; Analgesic Drug Products and Drug Safety &amp; Risk Management 12/20: PDUFA: $JAZZ solriamfetol (obstructive sleep apnea) 2019",,,#FDA,1074489490402623489,https://twitter.com/semodough/status/1074489490402623489
2018-12-13 18:10:10,MCPRllc,,0,0,0,"Psychiatrist & Sleep Medicine Specialist Dr. Alex Dimitriu was quoted in Reuters Health, MDLinx, about Solriamfetol. http://ow.ly/BaY430mYG0u #solriamfetol #excessivesleepiness #sleepproblems #dralexdimitriu",,,#solriamfetol #excessivesleepiness #sleepproblems #dralexdimitriu,1073278925055426566,https://twitter.com/MCPRllc/status/1073278925055426566
2018-12-13 11:18:19,CowenResearch,,0,0,1,"Ken Cacciatore publishes updated thoughts on $JAZZ ahead of the December 20th PDUFA date for Solriamfetol",,,,1073175276333514753,https://twitter.com/CowenResearch/status/1073175276333514753
2018-12-10 18:38:09,pontepedrat,,0,1,4,"Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea (TONES 3): A Randomized Controlled Trial | American Journal of Respiratory and Critical Care Medicine | Articles in Press https://www.atsjournals.org/doi/abs/10.1164/rccm.201806-1100OC",,,,1072198803472691201,https://twitter.com/pontepedrat/status/1072198803472691201
2018-12-07 20:47:11,COPD_bio,,0,1,0,"Solriamfetol for Excessive Sleepiness in Obstructive Sleep Apnea TONES 3 A Randomized Controlled Trial.: Primary treatment of obstructive sleep apnea can be accompanied by a persistence of excessive sleepiness despite adherence. Furthermore effectiveness… http://bioportfol.io/Qt5Tkp",,,,1071144111372066816,https://twitter.com/COPD_bio/status/1071144111372066816
2018-11-27 16:35:10,EURegulatory,,0,0,0,"Opinion/decision on a Paediatric investigation plan (PIP): (R)-2-amino-3-phenylpropylcarbamate hydrochloride (solriamfetol), decision type: , therapeutic area: Neurology, PIP number: P/0207/2018: https://ift.tt/2BBmSje #pharma #regulatory",,,#pharma #regulatory,1067456807877206017,https://twitter.com/EURegulatory/status/1067456807877206017
2018-11-25 20:59:04,Sleep_Bio,,0,1,0,"Solriamfetol for the treatment of excessive sleepiness in obstructive sleep apnea A placebocontrolled randomizedwithdrawal study. http://bioportfol.io/Qs58sk #sleep",,,#sleep,1066798447263531008,https://twitter.com/Sleep_Bio/status/1066798447263531008
2018-11-23 08:18:22,IllingworthInfo,,0,0,0,"Solriamfetol for the treatment of excessive sleepiness in obstructive… https://goo.gl/fb/F42utB #eprompt #respire",,,#eprompt #respire,1065882232819052544,https://twitter.com/IllingworthInfo/status/1065882232819052544
2018-11-13 00:13:27,marclefrancois4,,0,0,0,"Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol https://www.marclefrancois.net/2018/11/12/jazz-pharmaceuticals-submits-marketing-authorization-application-to-european-medicines-agency-for-solriamfetol/",,,,1062136324042485765,https://twitter.com/marclefrancois4/status/1062136324042485765
2018-11-09 21:26:12,MaisaCorp,,0,0,0,"$JAZZ has filing an application with European regulators seeking marketing authorization for its solriamfetol medication to improve wakefulness and reduce excessive daytime sleepiness in adult patients with narcolepsy or obstructive sleep apnea",,,,1061007067492818949,https://twitter.com/MaisaCorp/status/1061007067492818949
2018-11-09 13:29:17,HSMN_com,,0,0,0,"HSMN: Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea https://shar.es/aamxo1",,,,1060887050285531136,https://twitter.com/HSMN_com/status/1060887050285531136
2018-11-09 11:47:06,DennisPartners,,0,0,0,"Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy ",,,,1060861335565590528,https://twitter.com/DennisPartners/status/1060861335565590528
2018-11-09 11:44:43,politicalHEDGE,,0,0,0,"#MustRead -&gt; Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness https://hedgeaccordingly.com/jazz-pharmaceuticals-submits-marketing-authorization-application-to-european-medicines-agency-for-solriamfetol-as-a-treatment-to-improve-wakefulness-and-reduce-excessive-daytime-sleepiness-in-adult-pa/?utm_source=ReviveOldPost&amp;utm_medium=social&amp;utm_campaign=ReviveOldPost #prnewswire",,,#MustRead #prnewswire,1060860733301383169,https://twitter.com/politicalHEDGE/status/1060860733301383169
2018-11-09 10:50:35,CrweWorld,,0,0,0,"Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a http://crweworld.com/article/news-provided-by-pr-newswire/871516/jazz-pharmaceuticals-submits-marketing-authorization-application-to-european-medicines-agency-for-solriamfetol-as-a-treatment-to-improve-wakefulness-and-reduce-excessive-daytime-sleepiness-inn-adult-patients-with-narcolepsy-or-obstructive-sleep-apnea",,,,1060847109698596865,https://twitter.com/CrweWorld/status/1060847109698596865
2018-11-09 08:23:11,SeattlesBanker,,0,0,0,"Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea https://prn.to/2FgmkDp",,,,1060810015471218688,https://twitter.com/SeattlesBanker/status/1060810015471218688
2018-11-09 08:10:22,HedgeBz,,0,0,0,"Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea https://hedgeaccordingly.com/jazz-pharmaceuticals-submits-marketing-authorization-application-to-european-medicines-agency-for-solriamfetol-as-a-treatment-to-improve-wakefulness-and-reduce-excessive-daytime-sleepiness-in-adult-pa/",,,,1060806792609968128,https://twitter.com/HedgeBz/status/1060806792609968128
2018-11-09 08:10:05,financialbuzz,,0,0,0,"Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol a.. http://financialbuzz.com/jazz-pharmaceuticals-submits-marketing-authorization-application-to-european-medicines-agency-for-solriamfetol-as-a-treatment-to-improve-wakefulness-and-reduce-excessive-daytime-sleepiness-in-adult-patients-with-narcolepsy-or-obstructive-sleep-apnea-1232615",,,,1060806719654133761,https://twitter.com/financialbuzz/status/1060806719654133761
2018-11-09 07:20:29,Market_Screener,,0,0,1,"Jazz Pharmaceuticals : Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea http://www.4-traders.com/JAZZ-PHARMACEUTICALS-PLC-9829261/news/Jazz-Pharmaceuticals-Submits-Marketing-Authorization-Application-to-European-Medicines-Agency-for-27576834/",,,,1060794237116145664,https://twitter.com/Market_Screener/status/1060794237116145664
2018-11-09 07:18:02,RazzleTazzleMag,,0,0,0,"Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea http://razzletazzle.com/showbiz-rightnow/jazz-pharmaceuticals-submits-marketing-authorization-application-to-european-medicines-agency-for-solriamfetol-as-a-treatment-to-improve-wakefulness-and-reduce-excessive-daytime-sleepiness-in-adult-pa/2018/11/08/",,,,1060793622772178944,https://twitter.com/RazzleTazzleMag/status/1060793622772178944
2018-11-08 18:46:12,DrAlexConcorde,,0,1,1,"Solriamfetol Effective for Excessive Sleepiness in OSA, Narcolepsy http://ow.ly/oBhq50jCTHz",,,,1060604416338944000,https://twitter.com/DrAlexConcorde/status/1060604416338944000
2018-11-08 13:09:43,genphys,,0,0,0,"Solriamfetol effective for excessive sleepiness in OSA, narcolepsy - +GENERAL PHYSICS LABORATORY (GPL) Solriamfetol effective for excessive sleepiness in OSA, narcolepsy MD LinxFull coverage https://www.genphys.com/neuroscience/solriamfetol-effective-for-excessive-sleepiness-in-osa-narcolepsy",,,,1060519736071483392,https://twitter.com/genphys/status/1060519736071483392
2018-10-29 10:23:26,karacagurkan,,0,0,0,"Great article: Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea. http://QxMD.com/r/30365900 #ReadByQxMD",,,#ReadByQxMD,1056854011142397952,https://twitter.com/karacagurkan/status/1056854011142397952
2018-10-27 21:03:11,COPD_bio,,0,1,0,"Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea.: Obstructive sleep apnea OSA is highly prevalent and constitutes a major health hazard. Current pharmacotherapy is ineffective in correcting sleepdisordered breathing and is… http://bioportfol.io/QpjTLN",,,,1056290235158421504,https://twitter.com/COPD_bio/status/1056290235158421504
2018-10-27 10:07:15,SleepResearch_,,0,0,0,"Solriamfetol for the treatment of daytime sleepiness in obstructive sleep apnea. https://ift.tt/2qbRX6C",,,,1056125164478496768,https://twitter.com/SleepResearch_/status/1056125164478496768
2018-09-29 19:32:00,neurology_live,,0,1,0,"At the @ESRS_Sleep Congress, Geert Mayer, MD, spoke about @JazzPharma's #solriamfetol (JZP-101), a selective dopamine and norepinephrine reuptake inhibitor, as a potential treatment of excessive sleepiness in #narcolepsy and #obstructivesleepapnea.",,@ESRS_Sleep @JazzPharma,#solriamfetol #narcolepsy #obstructivesleepapnea,1046120426831630336,https://twitter.com/neurology_live/status/1046120426831630336
2018-09-29 18:55:01,neurology_live,,0,0,0,"Geert Mayer, MD, discussed the results of a long-term study observing the safety and maintenance of efficacy of #solriamfetol (JZP-110) for treatment of excessive sleepiness associated with narcolepsy or OSA. ",,,#solriamfetol,1046111118484070400,https://twitter.com/neurology_live/status/1046111118484070400
2018-09-28 17:28:00,neurology_live,,0,0,0,"ICYMI: Geert Mayer, MD, shared data at #ESRS2018 from a phase III 12-week study evaluating #solriamfetol in participants adherent or nonadherent to primary #obstructivesleepapnea devices and whether the treatment had an impact on primary therapy use. https://www.neurologylive.com/conferences/esrs-2018/geert-mayer-md-solriamfetol-as-potential-therapy-for-excessive-sleepiness-in-narcolepsy-obstructive-sleep-apnea",,,#ESRS2018 #solriamfetol #obstructivesleepapnea,1045726833293983744,https://twitter.com/neurology_live/status/1045726833293983744
2018-09-28 13:15:00,neurology_live,,0,0,0,"At #ESRS2018, Geert Mayer, MD, spoke about #solriamfetol (JZP-101), a selective dopamine and norepinephrine reuptake inhibitor, as a potential treatment of excessive sleepiness in narcolepsy and #obstructivesleepapnea. https://www.neurologylive.com/conferences/esrs-2018/geert-mayer-md-solriamfetol-as-potential-therapy-for-excessive-sleepiness-in-narcolepsy-obstructive-sleep-apnea",,,#ESRS2018 #solriamfetol #obstructivesleepapnea,1045663164480679936,https://twitter.com/neurology_live/status/1045663164480679936
2018-09-20 11:02:43,neurochecklists,,0,4,6,"Something emerging: Solriamfetol for #narcolepsy https://bit.ly/2NWtoYR https://bit.ly/2DcXIu8 https://bit.ly/2pp1IxZ See neurochecklists for a concise take on narcolepsy treatment https://bit.ly/2DeK2Pt",,,#narcolepsy,1042730769901408256,https://twitter.com/neurochecklists/status/1042730769901408256
2018-09-05 15:48:00,neurology_live,,0,1,0,"The director of the Sleep-Wake Disorders Center at @MontefioreNYC spoke about the difficulties of treating sleepiness and what solriamfetol brings to the table. ",,@MontefioreNYC,,1037366746536189953,https://twitter.com/neurology_live/status/1037366746536189953
2018-08-21 15:26:35,qeastman,,0,0,0,"Jazz getting ready for expected approval of solriamfetol, wake promoting medication (To me, sounds like modafinil - opinions @HypersomniaNews?) PDUFA deadline = Dec 20",,@HypersomniaNews,,1031925540247281665,https://twitter.com/qeastman/status/1031925540247281665
2018-08-16 17:11:47,MedscapeCME,,0,0,0,"NOW LIVE: Solriamfetol 12-Week RDBPC Trial TEAEs- with Dr. Chad Ruoff, MD of @StanfordHealth",,@StanfordHealth,,1030140074955104256,https://twitter.com/MedscapeCME/status/1030140074955104256
2018-08-15 09:00:14,MontefioreNYC,,0,3,3,"Dr. Michael Thorpy shares his thoughts on #solriamfetol &amp; the difficulties of treating sleepiness via @neurology_live: http://ow.ly/VmwB30lpk5C. @EinsteinMed @byMattHoffman @EinsteinMed",,@neurology_live @EinsteinMed @byMattHoffman @EinsteinMed,#solriamfetol,1029653982115815424,https://twitter.com/MontefioreNYC/status/1029653982115815424
2018-08-14 16:39:00,neurology_live,,0,0,0,"#ICYMI: The director of the Sleep-Wake Disorders Center at @MontefioreNYC spoke about the difficulties of treating #sleepiness and what #solriamfetol brings to the table. https://www.neurologylive.com/clinical-focus/michael-thorpy-on-treating-excessive-sleepiness",,@MontefioreNYC,#ICYMI #sleepiness #solriamfetol,1029407048201469953,https://twitter.com/neurology_live/status/1029407048201469953
2018-08-13 12:54:00,neurology_live,,0,0,0,"The director of the Sleep-Wake Disorders Center at @MontefioreNYC spoke about the difficulties of treating #sleepiness and what #solriamfetol brings to the table. https://www.neurologylive.com/clinical-focus/michael-thorpy-on-treating-excessive-sleepiness",,@MontefioreNYC,#sleepiness #solriamfetol,1028988037139779590,https://twitter.com/neurology_live/status/1028988037139779590
2018-08-11 13:11:00,neurology_live,,0,0,0,"#ICYMI: In December, the #FDA will review an application for #solriamfetol for the treatment of excessive sleepiness associated with #narcolepsy or #OSA. Michael Thorpy, MBChB, spoke about the therapy's potential.",,,#ICYMI #FDA #solriamfetol #narcolepsy #OSA,1028267539489419266,https://twitter.com/neurology_live/status/1028267539489419266
2018-08-10 14:28:00,neurology_live,,0,0,0,"#ICYMI: Michael J. Thorpy, MBChB, from @MontefioreNYC, spoke about #solriamfetol’s success and the possibility of it treating other sleep conditions. https://www.neurologylive.com/clinical-focus/solriamfetols-potential-in-treating-sleep-conditions",,@MontefioreNYC,#ICYMI #solriamfetol,1027924529509584896,https://twitter.com/neurology_live/status/1027924529509584896
2018-08-09 21:11:00,neurology_live,,0,0,0,"In December, the #FDA will review an application for #solriamfetol for the treatment of excessive sleepiness associated with #narcolepsy or #OSA. Michael Thorpy, MBChB, spoke about the therapy's potential. https://www.neurologylive.com/clinical-focus/solriamfetols-potential-in-treating-sleep-conditions",,,#FDA #solriamfetol #narcolepsy #OSA,1027663559948476417,https://twitter.com/neurology_live/status/1027663559948476417
2018-08-09 14:07:00,neurology_live,,0,0,0,"Michael J. Thorpy, MBChB, from @MontefioreNYC, spoke about #solriamfetol’s success and the possibility of it treating other sleep conditions. https://www.neurologylive.com/clinical-focus/solriamfetols-potential-in-treating-sleep-conditions",,@MontefioreNYC,#solriamfetol,1027556857165082625,https://twitter.com/neurology_live/status/1027556857165082625
2018-07-14 09:00:53,NarcolepsyZzzzz,wake_up_bill,2,0,0,"While a generic version of Xyrem be a relief for many patients (and insurance companies' wallets), @JazzPharma will have to rely on solriamfetol to recoup their losses when this happens. The FDA's decision on market approval for this drug is scheduled for later this year.",,@JazzPharma,,1018057734523060225,https://twitter.com/NarcolepsyZzzzz/status/1018057734523060225
2018-07-12 18:34:02,RemRunner,GinaMcGalliard,1,0,1,"Yes, that would be the second treatment mentioned in the post, Solriamfetol!",,,,1017477197794238464,https://twitter.com/RemRunner/status/1017477197794238464
2018-07-10 13:31:37,jjgiablue,,0,0,0,"$JAZZ-Citi raises PT to $205 (from $162): why? (i) upside to consensus estimates, (ii) balance sheet optionality to support business development and revenue diversification; and (iii) increased confidence in the commercial opportunity for solriamfetol. $JAZZ just opened at $180",,,,1016676316173619208,https://twitter.com/jjgiablue/status/1016676316173619208
2018-07-09 19:30:26,MDEdgePsych,,0,1,0,"Studies based on phase 3 clinical trials of the investigational drug solriamfetol have found that it may be effective for improving next-day wakefulness and work productivity in people with #narcolepsy and obstructive #sleepapnea",,,#narcolepsy #sleepapnea,1016404227218866181,https://twitter.com/MDEdgePsych/status/1016404227218866181
2018-06-29 02:51:00,HealioIM,,0,0,0,"Solriamfetol safe, effective for excessive sleepiness, according to a presentation at #SLEEP2018: https://bit.ly/2IyL7PB #narcolepsy #sleepapnea",,,#SLEEP2018 #narcolepsy #sleepapnea,1012528832966885377,https://twitter.com/HealioIM/status/1012528832966885377
2018-06-28 19:31:19,HealioIM,,0,1,0,"Solriamfetol safe, effective for excessive sleepiness, according to a presentation at #SLEEP2018: https://bit.ly/2IyL7PB #narcolepsy #sleepapnea",,,#SLEEP2018 #narcolepsy #sleepapnea,1012418185738547201,https://twitter.com/HealioIM/status/1012418185738547201
2018-06-25 23:33:52,ATP_CME,,0,0,0,"Top story: Sleep Review on Twitter: ""In Phase 3 Study, Some Solriamfetol Doses … https://twitter.com/i/web/status/1011371461481783298, see more http://tweetedtimes.com/v/3400?s=tnp",,,,1011392061583618048,https://twitter.com/ATP_CME/status/1011392061583618048
2018-06-25 22:12:01,SleepReview,,0,2,5,"In Phase 3 Study, Some Solriamfetol Doses Improve Work and Activity Functioning for People with Narcolepsy https://buff.ly/2tugK8l #sleep2018",,,#sleep2018,1011371461481783298,https://twitter.com/SleepReview/status/1011371461481783298
2018-06-25 21:40:55,marclefrancois4,,0,0,0,"In Phase 3 Study, Some Solriamfetol Doses Improve Work and Activity Functioning for People with Narcolepsy https://www.marclefrancois.net/2018/06/25/in-phase-3-study-some-solriamfetol-doses-improve-work-and-activity-functioning-for-people-with-narcolepsy/",,,,1011363634533097472,https://twitter.com/marclefrancois4/status/1011363634533097472
2018-06-25 21:16:56,S_Forsythe_AHC,,0,0,0,"""In Phase 3 Study, Some Solriamfetol Doses Improve Work and Activity ... - Sleep Review"" http://zpr.io/67mPA",,,,1011357599311200256,https://twitter.com/S_Forsythe_AHC/status/1011357599311200256
2018-06-13 06:06:24,Echoraljpangio,,0,0,0,"New Drug for Narcolepsy, Sleep Apnea on the Horizon https://www.medscape.com/viewarticle/897944?src=soc_tw_share via @medscape Solriamfetol (JZP-110) is an investigational selective dopamine and norepinephrine reuptake inhibitor",,@Medscape,,1006779800017604609,https://twitter.com/Echoraljpangio/status/1006779800017604609
2018-06-08 20:00:39,NHausMD,,0,0,2,"RT @NeurologyToday: The June 7 Neurology Today issue is now live: Rehab therapy for #stroke may help #MS patients, #solriamfetol efficacy and safety on excessive sleepiness in #narcolepsy, CAR T-cell therapy and its link to neurotoxicity, and more. http://bit.ly/2rfnOEK",,@NeurologyToday,#stroke #MS #solriamfetol #narcolepsy,1005177806828040192,https://twitter.com/NHausMD/status/1005177806828040192
2018-06-08 13:00:48,NeurologyToday,,0,5,12,"#Solriamfetol found effective and safe for excessive sleepiness in #narcolepsy in a phase 3 trial in @GreenJournal. Here's why sleep experts are hopeful about it. http://bit.ly/2JmFcyg",,@GreenJournal,#Solriamfetol #narcolepsy,1005072148606668800,https://twitter.com/NeurologyToday/status/1005072148606668800
2018-06-07 15:00:51,NeurologyToday,,2,8,14,"The June 7 Neurology Today issue is now live: Rehab therapy for #stroke may help #MS patients, #solriamfetol efficacy and safety on excessive sleepiness in #narcolepsy, CAR T-cell therapy and its link to neurotoxicity, and more. http://bit.ly/2rfnOEK",,,#stroke #MS #solriamfetol #narcolepsy,1004739973772390401,https://twitter.com/NeurologyToday/status/1004739973772390401
2018-06-05 12:33:55,VetjobsdisABLED,,0,0,0,"Jazz Pharmaceuticals, Inc. wants a Sr Mgr, Sales Training, Solriamfetol in Philadelphia, PA: http://bit.ly/2M2rDWy",,,,1003978218750308353,https://twitter.com/VetjobsdisABLED/status/1003978218750308353
2018-06-05 04:13:12,marclefrancois4,,0,0,0,"Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sleepiness in Narcolepsy or Obstructive Sleep Apnea https://www.marclefrancois.net/2018/06/05/jazz-pharmaceuticals-presents-long-term-safety-and-efficacy-data-from-phase-3-tones-5-study-of-solriamfetol-for-excessive-sleepiness-in-narcolepsy-or-obstructive-sleep-apnea/",,,,1003852209946349578,https://twitter.com/marclefrancois4/status/1003852209946349578
2018-06-04 13:00:31,CheckOrphan,,0,0,1,"Jazz Pharmaceuticals Presents Data from Ph3 TONES 5 Study of Solriamfetol for Excessive Sleepiness in #Narcolepsy or Obstructive #SleepApnea — CheckOrphan http://ow.ly/wWeU30kkadC @rarediseaseuk @RareDiseasesIE @RareDiseases",,@rarediseaseuk @RareDiseasesIE @RareDiseases,#Narcolepsy #SleepApnea,1003622528999403521,https://twitter.com/CheckOrphan/status/1003622528999403521
2018-06-04 12:24:45,Briefingcom,,0,0,0,"$JAZZ: Jazz Pharma presents long-term safety and efficacy data from phase 3 tones 5 study of solriamfetol for... http://bit.ly/2sAAkyk",,,,1003613525623705600,https://twitter.com/Briefingcom/status/1003613525623705600
2018-06-04 04:10:04,financialbuzz,,0,0,0,"Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for .. http://financialbuzz.com/jazz-pharmaceuticals-presents-long-term-safety-and-efficacy-data-from-phase-3-tones-5-study-of-solriamfetol-for-excessive-sleepiness-in-narcolepsy-or-obstructive-sleep-apnea-1107905",,,,1003489034755190784,https://twitter.com/financialbuzz/status/1003489034755190784
2018-06-04 01:50:18,mitdoc,,0,1,2,"Improved work productivity in patients with #narcolepsy using #Solriamfetol #JZP-110. #SLEEP2018 #Nchat",,,#narcolepsy #Solriamfetol #JZP #SLEEP2018 #Nchat,1003453863301713921,https://twitter.com/mitdoc/status/1003453863301713921
2018-06-04 01:47:10,mitdoc,,0,1,3,"Use of #Solriamfetol #JZP-110 in the treatment of excessive daytime sleepiness in patients with #narcolepsy. #SLEEP2018. #Nchat",,,#Solriamfetol #JZP #narcolepsy #SLEEP2018 #Nchat,1003453074952916992,https://twitter.com/mitdoc/status/1003453074952916992
2018-06-04 00:59:56,TalkingScars,,0,0,0,"Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sleepiness in Narcolepsy or Obstructive Sleep Apnea: DUBLIN, June 3, 2018 /PRNewswire/ — Jazz Pharmaceuticals plc… http://dlvr.it/QW4d9m Automotive",,,,1003441188353929217,https://twitter.com/TalkingScars/status/1003441188353929217
2018-06-04 00:39:58,Autotestdrivers,,0,0,0,"Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sleepiness in Narcolepsy or Obstructive Sleep Apnea: DUBLIN, June 3, 2018 /PRNewswire/ -- Jazz Pharmaceuticals plc… http://wardsauto.com/%5Bprimary-term%5D/jazz-pharmaceuticals-presents-long-term-safety-and-efficacy-data-phase-3-tones-5-stud?utm_source=dlvr.it&amp;utm_medium=twitter Car Autos News",,,,1003436161291784192,https://twitter.com/Autotestdrivers/status/1003436161291784192
2018-06-04 00:23:22,FN_Press,,0,0,0,"Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol fo ",,,,1003431983228256256,https://twitter.com/FN_Press/status/1003431983228256256
2018-06-04 00:13:39,Briefingcom,,0,2,0,"$JAZZ: Jazz Pharma presents long-term safety and efficacy data from phase 3 tones 5 study of solriamfetol for... http://bit.ly/2sAAkyk",,,,1003429537785380864,https://twitter.com/Briefingcom/status/1003429537785380864
2018-06-03 22:43:39,CrweWorld,,0,0,0,"Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Exce http://crweworld.com/article/news-provided-by-pr-newswire/313425/jazz-pharmaceuticals-presents-long-term-safety-and-efficacy-data-from-phase-3-tones-5-study-of-solriamfetol-for-excessive-sleepiness-in-narcolepsy-or-obstructive-sleep-apnea",,,,1003406888732626944,https://twitter.com/CrweWorld/status/1003406888732626944
2018-06-03 22:03:34,w3wire,,0,0,0,"Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sleepiness in Narcolepsy or Obstructive Sleep Apnea http://networkurl.com/jazz-pharmaceuticals-presents-long-term-safety-and-efficacy-data-from-phase-3-tones-5-study-of-solriamfetol-for-excessive-sleepiness-in-narcolepsy-or-obstructive-sleep-apnea-300658773-html",,,,1003396803188985856,https://twitter.com/w3wire/status/1003396803188985856
2018-06-03 21:49:17,FN_News_en,,0,0,0,"Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol fo https://www.finanznachrichten.de/nachrichten-2018-06/43958345-jazz-pharmaceuticals-presents-long-term-safety-and-efficacy-data-from-phase-3-tones-5-study-of-solriamfetol-for-excessive-sleepiness-in-narcolepsy-or-008.htm",,,,1003393207479259138,https://twitter.com/FN_News_en/status/1003393207479259138
2018-06-03 21:45:56,ukcitymedia,,0,0,0,"Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sleepiness in Narcolepsy or Obstructive Sleep Apnea http://dlvr.it/QW43C0",,,,1003392366386900992,https://twitter.com/ukcitymedia/status/1003392366386900992
2018-06-03 21:36:01,ShareHRnews,,0,0,0,"Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sleepiness in Narcolepsy or Obstructive Sleep Apnea http://dlvr.it/QW41nw",,,,1003389868943130625,https://twitter.com/ShareHRnews/status/1003389868943130625
2018-06-03 21:08:59,RazzleTazzleMag,,0,0,0,"Jazz Pharmaceuticals Presents Long-Term Safety and Efficacy Data from Phase 3 TONES 5 Study of Solriamfetol for Excessive Sleepiness in Narcolepsy or Obstructive Sleep Apnea http://razzletazzle.com/showbiz-rightnow/jazz-pharmaceuticals-presents-long-term-safety-and-efficacy-data-from-phase-3-tones-5-study-of-solriamfetol-for-excessive-sleepiness-in-narcolepsy-or-obstructive-sleep-apnea/2018/06/03/",,,,1003383065115287552,https://twitter.com/RazzleTazzleMag/status/1003383065115287552
2018-05-07 06:10:02,SleepyHeadCtrl,,0,0,0,"Solriamfetol Improves Wake-Time in Narcolepsy Types 1 and 2 https://buff.ly/2r0o7Co",,,,993372365152284672,https://twitter.com/SleepyHeadCtrl/status/993372365152284672
2018-04-26 11:16:36,PowerofSleep,,0,1,1,"Solriamfetol Improves Wake-Time in Narcolepsy Types 1 and 2 ",,,,989463250705223681,https://twitter.com/PowerofSleep/status/989463250705223681
2018-04-25 22:00:12,medpagetoday,,0,1,0,"Solriamfetol showed significant improvement in the mean sleep latency Maintenance of Wakefulness Test for patients with narcolepsy during at the dosage levels 150 mg and 300 mg. #AANAM https://www.medpagetoday.com/meetingcoverage/aan/72532",,,#AANAM,989262828778508290,https://twitter.com/medpagetoday/status/989262828778508290
2018-04-25 19:41:43,indusneuro,,0,0,0,"Solriamfetol Improves Wake-Time in Narcolepsy Types 1 and 2 #Neurology http://dld.bz/gMjvy",,,#Neurology,989227977367019521,https://twitter.com/indusneuro/status/989227977367019521
2018-04-25 19:41:42,induspolicy,,0,0,0,"Solriamfetol Improves Wake-Time in Narcolepsy Types 1 and 2 #Hospital #Medicine http://dld.bz/gMjvy",,,#Hospital #Medicine,989227975420928001,https://twitter.com/induspolicy/status/989227975420928001
2018-04-25 19:36:56,indusgeri,,0,0,1,"Solriamfetol Improves Wake-Time in Narcolepsy Types 1 and 2 #Geriatrics http://dld.bz/gMjvy",,,#Geriatrics,989226772062523394,https://twitter.com/indusgeri/status/989226772062523394
2018-04-25 19:30:54,pmgmtsolutions,,0,0,0,"Solriamfetol Improves Wake-Time in Narcolepsy Types 1 and 2 http://ow.ly/Gk9p50hb3l6",,,,989225255058264064,https://twitter.com/pmgmtsolutions/status/989225255058264064
2018-04-25 18:31:58,StephBeale1,,0,0,0,"Solriamfetol Improves Wake-Time in Narcolepsy Types 1 and 2 http://dlvr.it/QQmrVh",,,,989210425978843136,https://twitter.com/StephBeale1/status/989210425978843136
2018-04-25 18:25:18,luciekaisin571,,0,0,0,"Solriamfetol Improves Wake-Time in Narcolepsy Types 1 and 2 http://bit.ly/2r4P9IT",,,,989208747133284353,https://twitter.com/luciekaisin571/status/989208747133284353
2018-04-24 23:06:13,NeuroAdvisor,,0,1,1,"Robust improvement in wakefullness, daytime sleepiness in #narcolepsy type 1/2 with treatment with solriamfetol https://bit.ly/2FeD8FB #sleepdisorders #AANAM",,,#narcolepsy #sleepdisorders #AANAM,988917054521593857,https://twitter.com/NeuroAdvisor/status/988917054521593857
2018-04-24 17:38:30,ohsuneuro,,0,1,0,"Dr Thorpy acknowledged that Solriamfetol has a non-specific mechanism for wakefulness so will potentially work in conditions other than narcolepsy (for example PD) but has not yet been studied in other dzs #AANAM",,,#AANAM,988834579292209152,https://twitter.com/ohsuneuro/status/988834579292209152
2018-04-24 17:38:02,HemiMalkki,,0,0,1,"Michael Thorpy presents phase 3 RCT results of #solriamfetol, a norepinephrine–dopamine reuptake inhibitor that can promote wakefulness without tolerance (12-week period) in #narcolepsy types 1 &amp; 2. #AANAM",,,#solriamfetol #narcolepsy #AANAM,988834464867401728,https://twitter.com/HemiMalkki/status/988834464867401728
2018-04-24 17:35:06,DrEdWild,,0,0,0,"Impressive results for solriamfetol in promoting wakefulness in narcolepsy. Will it be the new modafinil (including the Silicon Valley “nootropic” baggage)? #AANAM",,,#AANAM,988833726175072260,https://twitter.com/DrEdWild/status/988833726175072260
2018-04-24 17:30:29,Wissam1985,,0,1,0,"Solriamfetol at 300mg and 150mg reached statistical significance in all primary and secondary endpoints. #AANAM",,,#AANAM,988832564227072000,https://twitter.com/Wissam1985/status/988832564227072000
2018-04-24 17:28:14,Wissam1985,,0,0,1,"Solriamfetol a DNRI in phase 3 study for patients with narcolepsy types 1 and 2 resulted in an increase in sleep latency and a decrease in excessive sleepiness with a dose effect (higher doses with better and more sustained benefit) #AANAM",,,#AANAM,988831997844951040,https://twitter.com/Wissam1985/status/988831997844951040
2018-04-24 14:00:05,NeuroMonteEinst,,0,2,7,"Two of our faculty will be presenting at today's #AANAM clinical trials plenary: 1. Michael Thorpy: Phase 3 RCT of Solriamfetol (JZP-110) for #Narcolepsy 2. Richard Lipton: Phase 3 RCT of Eptinezumab for #ChronicMigraine",,,#AANAM #Narcolepsy #ChronicMigraine,988779613231841281,https://twitter.com/NeuroMonteEinst/status/988779613231841281
2018-04-04 10:30:26,CowenResearch,,0,0,0,"To gauge the potential impact of $JAZZ's Solriamfetol, Ken Cacciatore conducted a survey with neurologists specializing in sleep. Full report today",,,,981479096277446658,https://twitter.com/CowenResearch/status/981479096277446658
2018-03-17 13:05:15,medicalnewser,,0,0,0,"Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Ob...",,,,974995075406225408,https://twitter.com/medicalnewser/status/974995075406225408
2018-03-11 21:12:19,rockettickers,,0,0,1,"FDA Accepts Jazz Pharmaceuticals’ NDA for Solriamfetol Treatment in Patients with Narcolepsy and Sleep Apnea https://rockettickers.com/newsletter/fda-accepts-jazz-pharmaceuticals-nda-solriamfetol-treatment-patients-narcolepsy-sleep-apnea/",,,,972943323492167681,https://twitter.com/rockettickers/status/972943323492167681
2018-03-11 21:04:02,sonalsignals,,0,0,1,"FDA Accepts Jazz Pharmaceuticals’ NDA for Solriamfetol Treatment in Patients with Narcolepsy and Sleep Apnea https://www.sonalsignals.com/newsletter/fda-accepts-jazz-pharmaceuticals-nda-for-solriamfetol-treatment-in-patients-with-narcolepsy-and-sleep-apnea/",,,,972941240818982912,https://twitter.com/sonalsignals/status/972941240818982912
2018-03-09 11:00:33,biopharmaglobal,,0,0,1,"Jazz Pharmaceuticals Announces @US_FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive #Sleepiness Associated with #Narcolepsy or Obstructive Sleep Apnea ☞ Read more at http://ow.ly/J6R330iPlgn #regulatoryaffairs #orphandrug #raredisease #sleepapnea",,@US_FDA,#Sleepiness #Narcolepsy #regulatoryaffairs #orphandrug #raredisease #sleepapnea,972064592699576320,https://twitter.com/biopharmaglobal/status/972064592699576320
2018-03-09 11:00:33,jobsearchjungle,,0,0,0,"Jazz Pharmaceuticals Announces @US_FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive #Sleepiness Associated with #Narcolepsy or Obstructive Sleep Apnea ☞ Read more at http://ow.ly/J6R330iPlgn #regulatoryaffairs #orphandrug #raredisease #sleepapnea",,@US_FDA,#Sleepiness #Narcolepsy #regulatoryaffairs #orphandrug #raredisease #sleepapnea,972064591034318848,https://twitter.com/jobsearchjungle/status/972064591034318848
2018-03-06 22:55:04,johnp_driscoll,,0,0,0,". @JazzPharma Announces @US_FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with #Narcolepsy or Obstructive #SleepApnea https://buff.ly/2FdSdIq",,@JazzPharma @US_FDA,#Narcolepsy #SleepApnea,971157243524677633,https://twitter.com/johnp_driscoll/status/971157243524677633
2018-03-06 15:57:11,hmepartner,,0,0,0,"FDA Accepts New Drug Application for Solriamfetol https://paper.li/f-1503539799?read=http%3A%2F%2Fwww.americanpharmaceuticalreview.com%2F1315%2DNews%2F347627%2DFDA%2DAccepts%2DNew%2DDrug%2DApplication%2Dfor%2DSolriamfetol%2F",,,,971052077827936257,https://twitter.com/hmepartner/status/971052077827936257
2018-03-06 09:34:44,SleepAust,,0,1,2,"Looking forward to seeing the data; Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea https://www.benzinga.com/pressreleases/18/03/n11295222/jazz-pharmaceuticals-announces-fda-acceptance-of-nda-for-solriamfetol-",,,,970955830827692032,https://twitter.com/SleepAust/status/970955830827692032
2018-03-06 03:40:46,SOULKIF,,0,0,0,"FDA Accepts New Drug Application for Solriamfetol | American Pharmaceutical Review - The Review of American Pharmaceutical Business &amp; Technology http://www.americanpharmaceuticalreview.com/1315-News/347627-FDA-Accepts-New-Drug-Application-for-Solriamfetol/ via @American Pharmaceutical Review",,@American,,970866755206811649,https://twitter.com/SOULKIF/status/970866755206811649
2018-03-06 03:40:43,DOCTORHELLOW8YM,,0,0,0,"FDA Accepts New Drug Application for Solriamfetol https://lnkd.in/euQHKFh",,,,970866742871445504,https://twitter.com/DOCTORHELLOW8YM/status/970866742871445504
2018-03-05 23:36:37,BluePrintOrphan,,0,0,0,"#FDA accepted Jazz Pharmaceuticals' New Drug Application for Solriamfetol for excessive sleepiness associated with narcolepsy or obstructive sleep apnea. #RareDiseases #Narcolepsy",,,#FDA #RareDiseases #Narcolepsy,970805312251817984,https://twitter.com/BluePrintOrphan/status/970805312251817984
2018-03-05 23:03:20,pharma_global,,0,0,0,"FDA Accepts for Jazz Pharmaceutical's New Drug Application for Solriamfetol (JZP-110) for… https://goo.gl/fb/mjPHjs",,,,970796936067461126,https://twitter.com/pharma_global/status/970796936067461126
2018-03-05 21:53:19,pharma_global,,0,0,0,"FDA Accepts for Jazz Pharmaceutical's New Drug Application for Solriamfetol (JZP-110) for… https://goo.gl/fb/w6ARUH",,,,970779313703448576,https://twitter.com/pharma_global/status/970779313703448576
2018-03-05 21:52:58,pharma_global,,0,0,0,"FDA Accepts for Jazz Pharmaceutical's New Drug Application for Solriamfetol (JZP-110) for… https://goo.gl/fb/6Mdvhn",,,,970779227636330496,https://twitter.com/pharma_global/status/970779227636330496
2018-03-05 17:00:42,CheckOrphan,,0,0,0,"#JazzPharmaceuticals Announces FDA Acceptance of NDA for #Solriamfetol (JZP-110) for Excessive Sleepiness Associated with #Narcolepsy or Obstructive Sleep #Apnea — CheckOrphan http://ow.ly/O9uc30iLicj @RareDiseases @rarediseaseuk @eurordis",,@RareDiseases @rarediseaseuk @eurordis,#JazzPharmaceuticals #Solriamfetol #Narcolepsy #Apnea,970705673502838784,https://twitter.com/CheckOrphan/status/970705673502838784
2018-03-05 07:29:01,KesterWong,,0,0,0,"US market will have a new eugeroic (#Solriamfetol) competitor to treat narcolepsy, which directly competes with Modafinil, Armodafinil, etc. Earliest availability in 2019. SK Biopharma also plans to IPO. #Nootropics #brainhack",,,#Solriamfetol #Nootropics #brainhack,970561807956918275,https://twitter.com/KesterWong/status/970561807956918275
2018-03-04 17:02:38,HottestStockNow,,0,0,0,"FDA Accepts $JAZZ 's NDA for Solriamfetol for Excessive Sleepiness Associated w/ Narcolepsy/Obstructive Sleep Apnea ",,,,970343773308948485,https://twitter.com/HottestStockNow/status/970343773308948485
2018-03-04 12:01:36,Jobs_Board,,0,0,0,"Jazz Pharmaceuticals: Director, Sleep Marketing, Solriamfetol (... http://www.jobs.as/job/17129120/Director-Sleep-Marketing-Solriamfetol/",,,,970268017958547456,https://twitter.com/Jobs_Board/status/970268017958547456
2018-03-02 16:53:25,jttdmd,,0,0,0,"Jazz Pharmaceuticals (JAZZ) Announces FDA Acceptance of NDA for Solriamfetol http://www.streetinsider.com/Corporate+News/Jazz+Pharmaceuticals+%28JAZZ%29+Announces+FDA+Acceptance+of+NDA+for+Solriamfetol/13894521.html via @Street_Insider",,@Street_Insider,,969616680371372032,https://twitter.com/jttdmd/status/969616680371372032
2018-03-02 15:40:39,mitdoc,,0,0,0,"Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Daytime Sleeiness in #narcolepsy. #Nchat http://prn.to/2oCwsf9",,,#narcolepsy #Nchat,969598364768718848,https://twitter.com/mitdoc/status/969598364768718848
2018-03-02 15:33:11,Briefingcom,,0,0,0,"$JAZZ: Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol http://bit.ly/2Fkeqrk",,,,969596485716160513,https://twitter.com/Briefingcom/status/969596485716160513
2018-03-02 14:17:56,FinanzLinksUS,,0,0,0,"FDA accepts Jazz Pharma's solriamfetol application for excessive sleepiness in patients with narcolepsy or obstructive sleep apnea http://dlvr.it/QJSDrt INVESTINGcom",,,,969577551717740545,https://twitter.com/FinanzLinksUS/status/969577551717740545
2018-03-02 14:17:07,7LadyQ,,0,0,0,"$JAZZ FDA accepts Jazz Pharma's solriamfetol application for excessive sleepiness in patients with narcolepsy or obstructive sleep apnea",,,,969577344389337089,https://twitter.com/7LadyQ/status/969577344389337089
2018-03-02 14:12:25,Manualinfo,,0,0,0,"FDA accepts Jazz Pharma's solriamfetol application for excessive sleepiness in patients with narcolepsy or obstructive sleep apnea http://ift.tt/2FLtIU5",,,,969576162480488448,https://twitter.com/Manualinfo/status/969576162480488448
2018-03-02 14:10:04,newsinvesting,,0,0,0,"FDA accepts Jazz Pharma's solriamfetol application for excessive sleepiness in patients with narcolepsy or... - https://invst.ly/6sz00",,,,969575570186145792,https://twitter.com/newsinvesting/status/969575570186145792
2018-03-02 14:09:48,financialbuzz,,0,0,0,"Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associa.. http://financialbuzz.com/jazz-pharmaceuticals-announces-fda-acceptance-of-nda-for-solriamfetol-jzp-110-for-excessive-sleepiness-associated-with-narcolepsy-or-obstructive-sleep-apnea-1021464",,,,969575503685328897,https://twitter.com/financialbuzz/status/969575503685328897
2018-03-02 14:00:52,InvestingStockz,,0,0,0,"FDA accepts Jazz Pharma's solriamfetol application for excessive sleepiness in patients with narcoleps... - https://invst.ly/6sz00",,,,969573254359810051,https://twitter.com/InvestingStockz/status/969573254359810051
2018-03-02 13:54:37,RazzleTazzleMag,,0,0,0,"Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea http://razzletazzle.com/showbiz-rightnow/jazz-pharmaceuticals-announces-fda-acceptance-of-nda-for-solriamfetol-jzp-110-for-excessive-sleepiness-associated-with-narcolepsy-or-obstructive-sleep-apnea/2018/03/02/",,,,969571682464694272,https://twitter.com/RazzleTazzleMag/status/969571682464694272
2018-03-02 13:54:17,MineForSale,,0,0,0,"Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness #mining https://minelistings.com/mine-news/jazz-pharmaceuticals-announces-fda-acceptance-of-nda-for-solriamfetol-jzp-110-for-excessive-sleepiness-associated-with-narcolepsy-or-obstructive-sleep-apnea/?utm_campaign=twitter&amp;utm_medium=twitter&amp;utm_source=twitter",,,#mining,969571596406059010,https://twitter.com/MineForSale/status/969571596406059010
2018-03-02 13:51:44,MarketCurrents,,0,0,0,"FDA accepts Jazz Pharma's solriamfetol application for excessive sleepiness in patients with nar... https://seekingalpha.com/news/3336102-fda-accepts-jazz-pharmas-solriamfetol-application-excessive-sleepiness-patients-narcolepsy?source=feed_f #premarket $JAZZ",,,#premarket,969570957412175878,https://twitter.com/MarketCurrents/status/969570957412175878
2018-03-02 13:50:32,BeyondReWA,,0,0,0,"Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated https://beyondwa.com/news/jazz-pharmaceuticals-announces-fda-acceptance-of-nda-for-solriamfetol-jzp-110-for-excessive-sleepiness-associated-with-narcolepsy-or-obstructive-sleep-apnea/",,,,969570656575807488,https://twitter.com/BeyondReWA/status/969570656575807488
2018-03-02 13:36:55,stocknewsdotcom,,0,0,0,"$JAZZ Announces FDA Acceptance of NDA for Solriamfetol https://stocknews.com/news/jazz-announces-fda-acceptance-of-nda-for-solriamfetol/",,,,969567229711921153,https://twitter.com/stocknewsdotcom/status/969567229711921153
2018-03-02 13:33:05,canuck2usa,,0,2,0,"Jazz Pharmaceuticals Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea $JAZZ https://pro.benzinga.com @benzinga",,@Benzinga,,969566264585633794,https://twitter.com/canuck2usa/status/969566264585633794
2018-03-02 13:30:28,BioRunUp,,0,1,1,"$JAZZ Announces FDA Acceptance of NDA for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea PDUFA 12/20/18",,,,969565604070879233,https://twitter.com/BioRunUp/status/969565604070879233
2018-02-18 18:24:00,Greg5thTrad,,1,0,0,"Upcoming week: #FDA watch: Jazz Pharmaceuticals $JAZZ is expected to hear from the regulator on a review for sleep disorder treatment solriamfetol ",,,#FDA,965290820642459648,https://twitter.com/Greg5thTrad/status/965290820642459648
2018-02-04 13:12:09,veteranjobboard,,0,0,0,"Product Manager, Thought Leader Liaison, Solriamfetol http://dlvr.it/QDydS8 #applynow",,,#applynow,960138911107334144,https://twitter.com/veteranjobboard/status/960138911107334144
2018-01-23 19:00:38,MGTCandidates,,0,0,0,"Senior Product Manager, Sleep, Solriamfetol - Palo Alto, CA, , USA #jobs #Palo Alto pls RT: Jazz Pharmaceuticals is an international biopharmaceutical company focused on improving patients lives by identifying, developing and commercializing meaningful… http://dlvr.it/QCRpn7",,,#jobs #Palo,955877953035952128,https://twitter.com/MGTCandidates/status/955877953035952128
2018-01-18 06:15:28,medicalnewser,,0,0,0,"Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obst...",,,,953873454381576192,https://twitter.com/medicalnewser/status/953873454381576192
2018-01-05 15:54:32,MGTCandidates,,0,0,0,"Marketing Director Disease Awareness, Solriamfetol - Philadelphia, PA, , USA #jobs #Philadelphia pls RT: Jazz Pharmaceuticals is an international biopharmaceutical company focused on improving patients lives by identifying, developing and commercializing… http://dlvr.it/Q91hsL",,,#jobs #Philadelphia,949308141103071237,https://twitter.com/MGTCandidates/status/949308141103071237
2018-01-05 14:05:12,MGTCandidates,,0,0,0,"Marketing Director Disease Awareness, Solriamfetol - Philadelphia, PA, , USA #jobs #Philadelphia pls RT: Jazz Pharmaceuticals is an international biopharmaceutical company focused on improving patients lives by identifying, developing and commercializing… http://dlvr.it/Q9109s",,,#jobs #Philadelphia,949280625625767937,https://twitter.com/MGTCandidates/status/949280625625767937
2018-01-01 19:03:16,johnp_driscoll,,0,0,1,"New Drug Application Submitted for Solriamfetol (JZP-110) for Excessive Sleepiness Associated with #Narcolepsy and Obstructive #SleepApnea",,,#Narcolepsy #SleepApnea,947906084089532418,https://twitter.com/johnp_driscoll/status/947906084089532418
2017-12-25 09:09:14,Jobs__Marketing,,0,0,0,"Philadelphia PA USA - #Marketing Director Disease Awareness Solriamfetol - The Marketing Director Disease Education for S http://twib.in/l/j86gXAaxXyeK #CAREER #WORK #JOB",,,#Marketing #CAREER #WORK #JOB,945219875605237760,https://twitter.com/Jobs__Marketing/status/945219875605237760
2017-12-25 04:02:31,Jobs__Marketing,,0,0,0,"Philadelphia PA USA - #Marketing Director Disease Awareness Solriamfetol - The Marketing Director Disease Education for S http://twib.in/l/geKgGqr7Ej96 #CAREER #WORK #JOB",,,#Marketing #CAREER #WORK #JOB,945142687115726849,https://twitter.com/Jobs__Marketing/status/945142687115726849
2017-12-22 13:51:49,Cortellis,,0,0,2,"Jazz Pharmaceuticals files its selective dopamine and norepinephrine reuptake Inhibitor solriamfetol for US approval for excessive daytime sleepiness and in narcolepsy and in obstructive sleep apnea; Cortellis WW Consensus forecast sales are $525.50 million in 2023",,,,944203828659916801,https://twitter.com/Cortellis/status/944203828659916801
2017-12-22 01:57:05,hmepartner,,0,0,0,"Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated ... https://paper.li/f-1503539799?read=http%3A%2F%2Fwww.financialbuzz.com%2Fjazz%2Dpharmaceuticals%2Dsubmits%2Dnew%2Ddrug%2Dapplication%2Dfor%2Dsolriamfetol%2Djzp%2D110%2Dfor%2Dexcessive%2Dsleepiness%2Dassociated%2Dwith%2Dnarcolepsy%2Dand%2Dobstructive%2Dsleep%2Dapnea%2D963766",,,,944023960240427009,https://twitter.com/hmepartner/status/944023960240427009
2017-12-21 23:03:17,HottestStockNow,,0,0,0,"$JAZZ Submits NDA to FDA for Solriamfetol for Excessive Sleepiness Associated w/ Narcolepsy, Obstructive Sleep Apnea ",,,,943980222206144513,https://twitter.com/HottestStockNow/status/943980222206144513
2017-12-21 19:12:04,PCSFortMyers,,0,0,0,"New Drug Application Submitted for Solriamfetol (JZP-110) for Excessive Sleepiness Associated ... http://dlvr.it/Q73gGj",,,,943922033393405952,https://twitter.com/PCSFortMyers/status/943922033393405952
2017-12-21 17:32:32,semodough,,0,0,1,"Cowen $JAZZ NDA for solriamfetol submitted launch in early 2019. efficacy and safety profile, our consultants believe that solriamfetol is a best-in-class and likely $750MM+ long duration product",,,,943896985060495361,https://twitter.com/semodough/status/943896985060495361
2017-12-21 15:31:37,Briefingcom,,0,0,0,"$JAZZ: Jazz Pharma submits NDA to the FDA seeking marketing approval for solriamfetol for the treatment of excessive... http://bit.ly/2kTnM17",,,,943866553308561408,https://twitter.com/Briefingcom/status/943866553308561408
2017-12-21 14:14:43,HSMN_com,,0,0,0,"News for Medical Independent Sales Representatives and Medical Distributors: #JazzPharmaceuticals Submits New Drug Application for #Solriamfetol (JZP-110) for Excessive Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnea https://shar.es/1MQufR",,,#JazzPharmaceuticals #Solriamfetol,943847203084361728,https://twitter.com/HSMN_com/status/943847203084361728
2017-12-21 14:08:30,FinanzLinksUS,,0,0,0,"Jazz Pharma submits U.S. marketing application for solriamfetol http://dlvr.it/Q71gLc INVESTINGcom",,,,943845638256525317,https://twitter.com/FinanzLinksUS/status/943845638256525317
2017-12-21 14:01:52,financialbuzz,,0,0,0,"Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated.. http://financialbuzz.com/jazz-pharmaceuticals-submits-new-drug-application-for-solriamfetol-jzp-110-for-excessive-sleepiness-associated-with-narcolepsy-and-obstructive-sleep-apnea-963766",,,,943843969770725378,https://twitter.com/financialbuzz/status/943843969770725378
2017-12-21 14:00:06,InvestingStockz,,1,0,0,"Jazz Pharma submits U.S. marketing application for solriamfetol - https://invst.ly/65kdg",,,,943843525845766144,https://twitter.com/InvestingStockz/status/943843525845766144
2017-12-21 13:56:10,RazzleTazzleMag,,0,0,0,"Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated… http://razzletazzle.com/showbiz-rightnow/jazz-pharmaceuticals-submits-new-drug-application-for-solriamfetol-jzp-110-for-excessive-sleepiness-associated-with-narcolepsy-and-obstructive-sleep-apnea/2017/12/21/",,,,943842532122857472,https://twitter.com/RazzleTazzleMag/status/943842532122857472
2017-12-21 13:56:08,lifeoncoin,,0,0,0,"""BRIEF-Jazz Pharma Submits New Drug Application For Solriamfetol (JZP-110)"" ",,,,943842524971532288,https://twitter.com/lifeoncoin/status/943842524971532288
2017-12-21 13:55:52,7LadyQ,,0,0,0,"$JAZZ Jazz Pharma submits U.S. marketing application for solriamfetol",,,,943842456860348418,https://twitter.com/7LadyQ/status/943842456860348418
2017-12-21 13:54:15,nycsocialg,,0,0,0,"BRIEF-Jazz Pharma Submits New Drug Application For Solriamfetol (JZP-110) ",,,,943842051787051008,https://twitter.com/nycsocialg/status/943842051787051008
2017-12-21 13:54:06,NTKRNow,,0,0,0,"Jazz Pharma submits U.S. marketing application for solriamfetol ",,,,943842013312700416,https://twitter.com/NTKRNow/status/943842013312700416
2017-12-21 13:52:51,Forex_warrior,,0,0,0,"Jazz Pharma submits U.S. marketing application for solriamfetol https://goo.gl/fb/UrUoyX",,,,943841697833865217,https://twitter.com/Forex_warrior/status/943841697833865217
2017-12-21 13:51:18,NTKRNow,,0,0,0,"BRIEF-Jazz Pharma Submits New Drug Application For Solriamfetol (JZP-110) ",,,,943841307495198720,https://twitter.com/NTKRNow/status/943841307495198720
2017-12-21 13:51:11,beeznescom,,0,0,0,"BRIEF-Jazz Pharma Submits New Drug Application For Solriamfetol (JZP-110) http://reut.rs/2BijNCl #BusinessNews #Companies",,,#BusinessNews #Companies,943841279934390272,https://twitter.com/beeznescom/status/943841279934390272
2017-12-21 13:48:55,MarketCurrents,,0,0,0,"Jazz Pharma submits U.S. marketing application for solriamfetol https://seekingalpha.com/news/3319636-jazz-pharma-submits-u-s-marketing-application-solriamfetol?source=feed_f #premarket $JAZZ",,,#premarket,943840708770664448,https://twitter.com/MarketCurrents/status/943840708770664448
2017-12-21 13:37:35,stocknewsdotcom,,0,0,0,"$JAZZ Submits NDA to the FDA seeking marketing approval for solriamfetol for the treatment of excessive sleepiness… https://stocknews.com/news/jazz-submits-nda-to-the-fda-seeking-marketing-approval-for-solriamfetol/",,,,943837858984579073,https://twitter.com/stocknewsdotcom/status/943837858984579073
2017-12-21 13:33:05,CrweWorld,,0,0,0,"Jazz Pharmaceuticals Submits New Drug Application for Solriamfetol (JZP-110) for Excessive Sleepiness Associated wit ",,,,943836723536162816,https://twitter.com/CrweWorld/status/943836723536162816
2017-11-01 10:35:44,medicaldialogs,,0,0,0,"Solriamfetol improves wakefulness in patients of obstructive sleep apnea - Medical Dialogues | @scoopit http://sco.lt/82CD57",,@scoopit,,925672699921424384,https://twitter.com/medicaldialogs/status/925672699921424384
